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Corneal blindness, resulting from corneal disease or injury, is the fourth leading cause 
of blindness worldwide. Corneal transplantation is the current standard treatment for 
restoring vision in many cases with a high success rate. However, high quality donors are 
in limited supply globally. In certain severe trauma cases, prompt treatment of the 
damaged cornea to preserve the corneal structure is critical. We address corneal blindness 
using two paradigms of reconstruction: replacement of the diseased cornea and prompt 
repair of the severely damaged cornea.  
For replacement strategies, we evaluated the clinically available gamma-irradiated 
cornea through physical and biological characterization. In addition, we developed a 
xenotransplantable corneal substitute using decellularizing methods and structural 
reconstruction technologies. For prompt repair of severely damaged corneas, we treated 
severe blast ocular injuries with our novel collagen-based membrane and sulfate-based 
hydrogel adhesive. In addition, cellulose contact lenses were developed for application in 
the event of severe corneal damage. The biocompatibility of the contact lens was 
evaluated with in vitro methods and two animal models. Moreover, we developed a 
surgical technique that improved application of the biomaterial onto the corneal surface 
with a rabbit model.   
The gamma-irradiated human cornea shared similar properties with the fresh human 
cornea. This suggests the gamma-irradiated human cornea would be a suitable corneal 
substitute in various ophthalmic applications. The animal tissue-based corneal substitute 
was macro- and microscopically reconstructed with our novel structural reconstruction 
technologies following invasive decellularization processes. In addition, the animal 
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tissue-based cornea showed ideal properties and demonstrated its potential as a corneal 
transplantation substitute in interlamellar and anterior lamellar keratoplasty animal 
models. The severe ocular blast injuries were effectively repaired with our collagen-based 
membrane and sulfate-based hydrogel adhesive. In addition, the cellulose bandage 
contact lens was developed and demonstrated its biocompatibility with both the rat 
subcutaneous implantation and the rabbit ocular irritation models. And the animal model 
for the contact lens application was greatly improved by our novel surgical technique. 
In conclusion, we have investigated biomaterial-based approaches to reconstruct the 
damaged cornea which may serve to reduce corneal blindness and restore vision. 
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1.  Introduction 
  
The cornea is the outermost layer of the eye and a highly organized transparent 
tissue. The cornea is vulnerable to damage via various traumatic, degenerative, 
dystrophic, infectious and inflammatory corneal disorders. However, the cornea is limited 
in its ability to self-repair and cannot fully regenerate without proper treatments. 
Insufficient treatment for a damaged cornea will mostly cause a deformation of the 
organized corneal structure, which if left untreated leads to corneal blindness. Clinically, 
corneal transplantation remains the standard method to restore vison and is relied upon to 
cover a wide range of corneal disorders. However, donor shortages limit the application 
of this largely successful treatment world-wide. In addition, in cases of severe corneal 
damage such as corneal penetration, prompt surgical closure is paramount to restore 
vision. Delayed structural reconstruction of the severely damaged cornea will result in 
visual impairment and may preclude a corneal transplantation. Biomaterials have the 
potential to restore vision by reconstructing the damaged cornea. As a corneal substitute, 
novel materials could replace the damaged cornea and overcome the donor shortage issue. 
In addition, specifically designed biomaterials could provide a method to promptly 
reconstruct the damaged cornea to prevent visual impairment and act as a bridge-to-
therapy to secondary reconstructive surgery including corneal transplantation.  
In the following dissertation, the author addresses corneal blindness with two 
reconstruction strategies paradigms: replacement of the diseased cornea and prompt 
repair of the severely damaged cornea using various biomaterials. Chapter 2 of this thesis 
reviews the structure and composition of the cornea, corneal blindness and its treatments 
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as well as contemporary biomaterial-based approaches for corneal reconstruction. In 
Chapter 3, we propose a biomaterial-based method to promptly repair severe blast ocular 
injury using our novel collagen-based membrane and sulfate-based hydrogel adhesive. In 
addition, we attempt to develop these materials by creating a 3D scaffold of collagen and 
incorporating antibiotics into the hydrogel adhesive. This method efficiently repairs 
severe war-type ocular damage for preservation of corneal structure and the two 
developed technologies improve their applicability to the battlefield.  
In Chapters 4 and 5, we investigate two tissue-derived biomaterials. We 
characterize the gamma-irradiated human cornea and the fresh human cornea to compare 
their physical and biological properties in chapter 4. The gamma-irradiated cornea is 
clinically available and could alleviate the donor shortage issue by reusing unsuitable 
donor corneas through engineering methods. Physical and biological characterization of 
the gamma and native corneas reveal similar properties, implying the gamma-irradiated 
human cornea could be a suitable corneal substitute. 
Chapter 5 describes how we develop an animal tissue-based corneal substitute 
with decellularization methods through our novel vitrification and material shaping 
methods from Chapter 3. Using established characterization methods from Chapter 4, we 
demonstrate our novel vitrification and two-mold method successfully reconstruct the 
damaged decellularized cornea after the decellularization process both macro- and 
microstructurally. In addition, two animal models support the conclusion that our 
engineered cornea has the potential to act as a xenotransplantable corneal substitute.   
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Chapter 6 describes a surgical technique I developed as a veterinary surgeon to 
address the reduced stability of biomaterials on the animal cornea because of the 
nictitating membrane. By fixing the nictitating membrane on the upper eyelid, stability of 
the biomaterial, especially the contact lens, is markedly increased and this technique 
contributes to a successful study documented in the following chapter. In Chapter 7, we 
describe the development of a cellulose bandage contact lens for preserving vision in the 
event of severe corneal damage that is applicable both in the battlefield and for civilians. 
In addition, we establish the biocompatibility of the cellulose hydrogels which may 











2. 1. Cornea 
 2. 1. 1. Anatomy and Physiology 
  The cornea is a transparent fibrous tunic, connected with the conjunctiva and the 
sclera in the limbus area. The tissue compromises 1/6 of the total surface of globe that 
covers the anterior chamber, iris and pupil [1]. Eye lids protect the cornea from the 
external environment and the nictitating membrane shares the protective function with 
eyelids in animals except in primates and humans [2]. The cornea is an avascular tissue. 
Instead of a vascular system, the supply of oxygen and nutrition, and the excretion of 
waste products are provided by the aqueous humor and tears. Sensory nerves, especially 
pain receptors, are richly distributed in the cornea and help to protect this tissue through 
their high sensitivity. Tear fluid always covers the corneal surface, which helps to 
maintain homeostasis of the corneal epithelium and prevents dehydration of cornea.  
In humans, the cornea consists of five morphologically recognized layers. From 
outside to inside, they are the epithelium, Bowman’s layer (absent in some animals), 
stroma, Descemet's membrane and endothelium. The epithelium is comprised of 5-7 
layers of non-keratinized epithelial cells which cover the anterior corneal surface. The 
epithelium has 3 different types of cells: superficial cells, wing cells and basal cells. 
                                                          
1
 Part of this chapter was previously published as a paper here: Elisseeff JE, Madrid MG, 
Lu Q, Chae JJ, Guo Q. (2013) “Future perspectives for regenerative medicine in 
ophthalmology” Middle East African journal of ophthalmology 20 (1): 38–45. 
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Unlike other types of epithelial cells, the columnar basal cells possess mitotic and 
proliferative activity [3, 4]. The columnar cells are hypothesized to drive their 
regenerative activity from limbal stem cells [5, 6]. After migration, columnar cells 
differentiate to wing cells and ultimately to superficial cells [3]. Each corneal epithelial 
cell is tightly connected with neighboring epithelial cells or corneal matrix that 
functionally prevents invasion of pathogens to the stroma. The Bowman’s layer (or 
Bowman’s membrane) is an acellular layer at the interface between the corneal 
epithelium and stroma and is considered a condensate of the most anterior portion of the 
stroma [7]. The function of this layer is not fully understood but the layer may contribute 
to maintaining corneal shape. This layer has some regenerative ability, but damage may 
lead to scarring. 
The corneal stroma comprises approximately 85% of the thickness of the cornea 
with an organized layer-by-layer connective tissue [7]. The main composition of the 
stroma is collagen (mainly type I collagen) and proteoglycans (dominantly decorin and 
lumican) [8] which work together to keep the stroma precisely organized and transparent. 
The collagen fibrils, consisting of collagen fibers, are uniformly positioned into lamellar 
and transverse layers that allow light transmittance without scattering [9, 10]. The stroma 
cell, the keratocyte, is sparsely distributed in the layer and is quiescent. However, when 
the cornea is injured, the cell can transform into a fibroblast that reconstructs the 
damaged cornea. In case of deep corneal injury, the fibroblast may form scar tissue that 
reduces transparency of the cornea [11]. The cornea is 75% to 85% water which is 
closely related to its transparency. When epithelium and endothelium is functionally 
damaged, deturgescence could be affected which allows an increase of 200% (epithelium) 
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and 500% (endothelium) in corneal thickness after 24 hours because of the influx of 
water [12]. Descemet’s membrane is the basement membrane of the corneal endothelium. 
Damage to this layer could result in the corneal rupture that would be expected to cause 
corneal edema. Although the ruptured area is covered by endothelial cells, the membrane 
is not regenerated.   
Endothelium is the innermost layer of the cornea with a monolayer of flattened 
endothelial cells [13]. Approximately 400,000 endothelial cells are arranged with a 
hexagonal mosaic pattern in this layer. The main function of this layer is pumping out 
water from the stromal layer using energy-dependent Na+/K+ adenosine triphosphatase 
(ATPase) pumps and other associated complexes [14, 15]. The compensatory ability is 
available with enlargement and migration of the remaining neighboring cells that covers 
the defective area after the loss of endothelial cells [16]. However, due to their limited 
regenerative ability, normal age-related loss or damage of endothelial cells could allow 
increased imbibition of water into stroma and lead to corneal swelling and finally to 
corneal blindness [15, 17].  
2. 1. 2. Function of cornea 
The main roles of the cornea could be simplified to protection, light transmission 
and refraction. The protective function from corneal structure integrity is critical since 
intraocular contents are vulnerable to the external environment. Mechanically, the highly 
organized corneal stroma consists of collagen lamellae which produce mechanical 
elasticity. This property of the cornea confers the ability to withstand biaxial load which 
renders mechanical protection. In addition, the cornea could protect the eye from 
7 
 
chemical and pathological insults with its specific epithelial structure. As described above, 
corneal epithelial cells are tightly connected to each other with tight junction complexes 
including desmosomes, adherens junctions and tight junctions, which prevent the passage 
of substances through the intercellular space. Moreover, the cornea has a light protective 
function. UV irradiation induces retinal damage by disruption of homeostasis, oxidative 
stress and DNA damage which leads to impairment of photoreceptors [18]. By blocking 
the UV light, the cornea associates with the lens to protect retina [19]. Optical clarity is 
one of fundamental properties of the cornea. The cornea allows transmittance of 
approximately 95% of light in the visible spectrum which activates photoreceptors of the 
retina. Ultra-structurally, small and nearly identical diameter collagen fibrils and 
symmetric interfibrillar spaces contribute to produce this great light transmittance ability. 
In addition, the highly organized and flattened lamellar structure of cornea transmits the 
light only in the forward direction which prevents light scattering [10]. Functionally, the 
corneal endothelium and epithelium maintain corneal deturgescence which prevents 
corneal swelling and increasing opacity. The cornea is the principle refractive tissue in 
the eye, contributing about 75% of total refraction [1].  The novel concave shape of 
cornea produces the refractive power that ensures visual acuity. Corneal curvature is 
governed by the intrinsic structure and extrinsic environment [7]. The rigidity of the 
anterior corneal stroma appears to have an especially important role in maintaining the 
corneal curvature [20]. When the cornea has an unfavorable curvature, refractive errors 
would reduce the quality of vision. However, several reports presented that corneal shape 
could be corrected over time with other ocular geometric changes [21-23]. The 
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mechanism concerning this correction is not clear but the anterior interweaving is 
considered to play some role in controlling curvature [1].  
 
2. 2. Corneal blindness and treatment  
  2. 2. 1. Corneal blindness and diseases 
The vulnerable cornea can be damaged through various reasons and it is well 
known that corneal blindness is the fourth leading cause of blindness worldwide [24]. 
The epidemiology of corneal blindness is complicated and varies with infectious, 
nutritional, inflammatory, inherited, iatrogenic and degenerative corneal diseases.  Those 
disorders could cause inappropriate corneal structure such as corneal scar formation that 
ultimately leads to visual impairment and corneal blindness [25].  
Corneal trauma causes various degrees of corneal damage from corneal erosion to 
corneal rupture. A good prognosis can be expected after mild corneal damage without 
surgical treatments if it is well controlled and treated. However, a moderate to deep 
traumatic corneal wound leads to corneal haze or scar formation during the natural 
healing process even when standard treatments are applied. In addition, severe corneal 
damage by trauma, such as a penetrating corneal wound or a blast injury leads to corneal 
blindness with high incidence and a bad prognosis can be expected. In those cases, 
surgical repair should be conducted in a timely manner to preserve the eye from 
endophthalmitis, tissue necrosis and ultimately visual impairment. 
Trachoma is a typical infection and the most common cause of blindness 
worldwide [26]. It is predominant in developing countries in Asia and Africa, and easily 
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controlled through public health interventions. However, trachoma is commonly found in 
children of developing countries and presents its specific symptom, recurrent follicular 
conjunctivitis. The symptom is problematic because it leads to corneal irritation with 
entropion and trichiasis, causing scarring and ultimately corneal blindness.  
Keratoconus is a bilateral, non-inflammatory and progressive corneal dystrophy 
with a high incidence, approximately 1 per 2000, in the general population [27]. The 
main symptom of keratoconus is the cornea becomes thinner and more concave shaped. 
This symptom alters corneal curvature and induces improper refractive power, 
astigmatism and nearsightedness. In addition, keratoconus causes corneal swelling which 
increases corneal opacity and scarring. Specifically designed contact lens would reduce 
astigmatism and somewhat improve visual quality. In addition, riboflavin crosslinking 
could slow the progression of the disease. However, the cornea will ultimately be opaque 
and lead to corneal blindness.  
Fuchs' dystrophy is the most common corneal endotheliopathy in the US [28]. 
The main symptom of this disorder is gradual endothelial cells deterioration without any 
specific incidents. When the compensatory ability is exhausted, the endothelium does not 
efficiently pump out water from the stromal layer and finally results in corneal swelling 
and visual distortion. In addition, the epithelium is damaged which would accelerate 
visual impairment.  
 Furthermore various inflammatory corneal diseases including Mooren’s ulcer and 
Steven’s Johnson Syndrome, nutritional diseases such as vitamin A deficiency and 
secondary ocular surfaces diseases cause corneal blindness.  
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 2. 2. 2. Corneal transplantation  
Although other treatments may be able to alleviate symptoms and reduce disease 
progress, corneal transplantation is the fundamental and gold standard treatment to 
restore vision from corneal blindness. The cornea is the most commonly transplanted 
tissue worldwide [25]. Due to its unique immune privilege, the success rate is relatively 
high [29]. However, the eye bank cannot provide a sufficient amount of high quality of 
donor tissue except in North America, resulting in long waiting lists for corneal 
transplantation in most countries [30].  Various corneal transplantation techniques are 
available depending on the clinical indication. Penetrating keratoplasty, anterior lamellar 
keratoplasty and endothelial keratoplasty are mostly applied and each method has its 
specific purpose. 
Penetrating keratoplasty (PK) is the replacement of all five layers of the cornea 
whereas lamellar keratoplasty targets  replacement of only diseased corneal layers [31]. 
Although this technique has been replaced by other lamellar keratoplasty techniques, PK 
remains the most common keratoplasty procedure worldwide [25, 31]. The procedure can 
be used in many indications of corneal diseases without limitations. In addition PK 
potentially provides the best optical or therapeutic results since this technique does not 
produce a lamellar interface between the donor and host tissue. However, PK increases 
the risk of many complications including epithelial and endothelial rejection, donor 
endothelial cell loss and astigmatism. Endothelial cell loss resulting in future corneal 
failure is especially common which led to the rapid adoption of other new procedures to 
replace PK [32, 33].  
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 Anterior lamellar keratoplasty (ALK) is the standard procedure used to replace 
epithelium and stromal tissue. Since host endothelial cells are retained and relatively 
unaffected after the procedure, ALK has significant merit concerning endothelial cell loss. 
In addition, this technique eliminates endothelial allograft rejection which is one of major 
complications in PK. However, technical difficulties including separation of anterior 
stroma layers from Descemet’s membrane limits widespread adoption of this procedure 
[25]. Remaining anterior stroma may reduce visual acuity by haze formation during the 
stromal healing process and astigmatism remains disadvantages of ALK. Deep anterior 
lamellar keratoplasty (DALK) is an advanced procedure that removes the entire corneal 
stroma with minimal damage to corneal endothelium. Due to the removal of whole 
stroma, this procedure could reduce the incidence of the remaining stroma-to-stroma 
interface which might limit the optimal visual quality in ALK. Using the big bubble 
technique, injection of air to separate Descemet’s membrane from the stroma, DALK 
procedure may allow full removal of corneal stroma.  
 Endothelial keratoplasty has replaced PK as a favorable procedure for treating 
endotheliopathy such as Fuch’s dystrophy. The technique initially strips the Descemet’s 
membrane and endothelium from the recipient cornea. After stripping, donor tissue is 
attached using air tamponade without sutures. Depending on remaining Descemet’s 
membrane, the technique is classified as Descemet Stripping Endothelial Keratoplasty 
(DSEK) or Descemet membrane endothelial keratoplasty (DMEK).  The best advantage 
of this procedure is predictable and rapid visual habitation. By elimination of astigmatism 
after PK, fast visual rehabilitation can be achieved.  However, the most common 
complications of endothelial keratoplasty are endothelial graft rejection, primary graft 
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failure, and iatrogenic glaucoma [34]. In addition, unpredictable donor lamellar adhesion 
resulting in dislocation limits widespread of this technique [35].  
 
2.  3.  Reconstruction of the cornea using biomaterials and tissue 
engineering approaches  
Biomaterial approaches have attempted to develop corneal substitutes using 
various approaches to address corneal blindness. Initially, a number of synthetic materials 
have been explored as biomaterials for the eye. While millions of contact lenses or 
various devices have been utilized on patients around the world, development of a 
synthetic corneal substitute has had little success [36]. In the meantime, the field of tissue 
engineering and regenerative medicine developed into a major force in creating tissue 
substitutes. The general approach of tissue engineering is to employ biomaterials as 
temporary scaffolds to support and direct cells to form new tissue. While tissue 
engineering has reached clinical testing and even commercialization for applications, 
including skin, bone and cartilage, it has been slow to reach ophthalmology and corneal 
reconstruction. There are a number of strategies to reconstruct the cornea with a 
regenerative medicine approach using biomaterials.  
2.3.1. Corneal substitutes 
For addressing the global shortage of high-quality donors for corneal 
transplantation, the importance of developing an optimal corneal substitutes are 
emphasized in the recent tissue engineering field. Optimal corneal substitutes must fulfill 
the natural function of cornea:  maintaining transparency; having an adequate refractive 
index; protecting the inner ocular structures from external hazards, including pathogens 
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and ultraviolet (UV) light; having proper mechanical properties to tolerate the intraocular 
pressure and allowing diffusion of oxygen and nutrients [37]. In addition, as biomaterials, 
they must be biocompatible, nontoxic, neither immunogenic nor mutagenic and integrate 
well with the recipients’ surrounding tissues and cells [1]. There are two main substitute 
categories: Synthetic keratoprostheses and tissue-engineered corneal substitutes. 
2. 3.1.1. Keratoprostheses 
The synthetic keratoprostheses (K-Pro) were the first corneal substitute developed. 
They consist of two main parts: The transparent optical center and the surrounding skirt 
designed to support the implant. Depending on the type of K-Pro, additional supporting 
components may be found [38]. The optical region is commonly made of plastic 
polymers, including poly (methyl methacrylate) (PMMA), poly(2-hydroxyethyl 
methacrylate) (pHEMA) and polydimethylsiloxane (PDMS), which do not integrate well 
with the native tissue. The skirt provides the mechanical stability and biological 
integration critical to reducing adverse results [30]. The major complications derive from 
integration problems and include device extrusion, stromal melting, epithelial thinning 
and persistent epithelial defects. An overview of available prostheses is provided below.  
The Boston K-Pro (Dohlman-Doane keratoprosthesis) is FDA approved and is 
considered the gold standard in synthetic corneal substitutes. Type 1 consists of a central 
PMMA optical region, a porous back plate and a titanium locking ring that locks on 
native corneal tissue. The type 2 K-Pro was designed for patients suffering from severe 
diseases of the ocular surface, such as Stevens–Johnson syndrome (SJS) and ocular 
cicatricial pemphigoid (OCP), who are unable to maintain eyelid function. With the 
exception of the additional anterior protruding rod in the central area, the Boston KPro types 1 
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and 2 have the same structure. Although recent reports indicate good clinical outcomes, 
there are still relatively high complication rates in the main indications such as SJS [39, 
40]. 
The osteo-odonto keratoprosthesis (OOKP), like the Boston type 2 K-Pro, is 
primarily used for patients with severe dry eye. The concept of the OOKP was derived  
from research showing that integration is maximized while immune reactions are 
minimized through the use of the patient’s own tissue, including cartilage [41], and tibial 
bone [42]. The OOKP uses a canine tooth, its alveolar bone and ligament as a skirt to 
support the central optic component. A retrospective study of the OOKP shows high 
retention rates (85%) over 19 years, including in SJS and OCP patients, with low 
complication rates [43]. Even with the additional complex and invasive surgical 
procedures and the risk of resorption of the tissue, the OOKP is the most successful and 
well known K-Pro in use today [36].  
The AlphaCor
TM
 K-Pro is manufactured by altering the water content in pHEMA 
during the polymerization of the optical center and the skirt. Unlike other K-Pros, the 
design of the AlphaCor
TM
 utilizes the interpenetrating polymer network to permanently 
connect the two regions. The porous pHEMA allows for the vigorous invasion of 
keratocytes, resulting in a better integration with host tissue [44]. Because of this stromal 
skirt repopulation, the retention rate is relatively high [45]. Unfortunately, even though 
there are promising short-term results, the fixation failures caused by stromal melting and 
intraoptic deposits still limit the usefulness of the AlphaCore
 TM




 2. 3. 1. 2. Bottom-up types of engineered corneal equivalent 
Bottom-up types of tissue engineering corneal substitutes promise to overcome 
the many challenges and deficiencies of synthetic materials. Tissue-engineered corneal 
substitutes are constructed by naturally generating an extracellular matrix (ECM) 
component with or without corneal cells. It is well established that the ECM directs the 
fate of cells, therefore, the fabrication of the proper ECM components could produce an 
ideal corneal substitute, able to mimic the native corneal function. Since the components 
of the ECM are natural (biological) polymers, there is higher biocompatibility and 
integration with host tissues when compared to synthetic polymeric materials, such as 
those in the different K-Pros. In addition, these substitutes can be used to generate a 
targeted corneal layer, such as the endothelium for Descemet’s stripping endothelial 
keratoplasty (DSEK). Cosmetically, the tissue-engineered cornea is more similar to 
native cornea than the K-Pros and has the potential to provide a long-term or even 
permanent tissue replacement, indistinguishable from the original tissue. 
Hydrogels are widely used as substitutes for various types of tissue and ECM. 
They are highly versatile materials that allow for the diffusion of oxygen and nutrients, 
have adjustable mechanical properties, can be designed to contain large volumes of water 
and are relatively biocompatible. The corneal stroma comprises roughly 85% of the 
corneal thickness and consists of keratocytes and ECM [7].  Since collagen type I is the 
predominant component of the corneal stromal ECM (approximately 70% of dry weight), 
it has been considered as the natural component to reconstruct it. As such, a corneal 
substitute was developed using highly cross- linked collagen hydrogels using N-(3-
dimethylaminopropyl)-N’-ethylcarbodiimide (EDC) and N-hydroxysuccinimide (NHS) 
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technology. It was successfully transplanted into several animal models, including guinea 
pig, dog and pig, either as a deep lamellar or full thickness keratoplasty [46]. Recently, 
these collagen-based corneal substitutes were transplanted into 10 patients in a phase I 
clinical trial [47].After 24 months, there were no severe adverse effects and the implants 
allowed for epithelial and keratocyte migration in all patients, as well as slow nerve 
invasion in the younger patients. Eight of the patients, however, developed focal hazing, 
which may critically reduce vision quality. A long-term clinical study, with a large 
number of patients and further development of the material, will be needed if the material 
is to be used in clinical practice. 
Non-cross-linked collagen hydrogels are generally composed of loosely packed 
collagen fibers, strongly contrasting with the highly condensed and well organized 
collagen fibers found in the stromal layer of the cornea. Recently, Takezawa et al. 
developed a type I collagen hydrogel membrane using a novel processing method, called 
vitrification, that we have been optimizing for ocular applications [48, 49]. The collagen 
hydrogel membrane was named vitrigel, and is made from a type I collagen solution 
prepared through a three-stage sequence: Gelation, vitrification and rehydration [50]. The 
vitrification step is unique in that it allows the collagen hydrogel to dry slowly so the 
collagen fibers can be reorganized and develop new hydrogen bonding interactions with 
each other. More importantly, unlike the opaque and comparably weak non-cross-linked 
collagen hydrogels, vitrigels are clear and possess greatly enhanced mechanical 
properties that are critical for ocular applications. Most important, with this method we 
begin to approach the more complex structure of the native cornea matrix with collagen 
fibers that are critical for both physical and biological function of the tissue. Using 
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vitrigel, we evaluated the reconstruction of the three different corneal layers: Epithelium, 
stroma and endothelium [51]. Human LSCs were cultured successfully on the vitrigel, 
demonstrating maintenance and upregulated expression of the putative stem cell markers 
ABCG2 and p63, respectively, thus indicating that vitrigels can preserve the LSC 
phenotype. In vivo, keratocytes exhibit a characteristic dendritic morphology with 
extensive intercellular contacts [50]. However, when the corneal stroma is wounded, the 
cells transform either to wound-healing fibroblasts or to scar-forming myofibroblasts, 
which form a disorganized and opaque ECM. Therefore, it is desirable to promote the 
fibroblast phenotype and proliferative activity of keratocyte wound healing. Keratocytes 
cultured on vitrigels exhibit enhanced dendritic branch density and length, compared to 
tissue culture plate control. An enhanced expression of aldehyde dehydrogenase (ALDH) 
and keratocan (important markers of keratocyte phenotype and function) was also 
observed. These results suggest that the use of vitrigel materials may benefit corneal 
stromal regeneration, as well as promote better integration and cellular function in vivo. 
Finally, promising results were obtained for endothelial culture on the vitrigels. In short, 
vitrigels demonstrate unique advantages over other materials; these include optical 
transparency, mechanical strength and handling convenience. They are also easy to 
process, store and manipulate. These properties make vitrigels novel and very promising 
options for corneal tissue engineering and regeneration.  
2. 3. 1. 3. Tissue-based corneal equivalent 
Engineering a new cornea or subset of the cornea remains a long-term interest. 
Beside bottom-up approaches, tissue-based top-down ones are emerging as promising 
strategies. To provide surgeons with a corneal substitute, tissue-based corneal substitute 
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has a structure similar to native tissue. Xenotransplantation can be employed to obtain 
corneal substitutes, particularly in developing countries that suffer from low donor rates 
because of regional, cultural and other institutional issues [52]. Although rejection is the 
greatest obstacle to widespread use of xenotransplantation, fully decellularized 
components of the animal tissue may be clinically applied without immune rejection [53]. 
A good example of this approach is the success of porcine heart valve transplantation 
[54]. Decellularization can be applied, not only to xenogeneic, but also to allogeneic 
cornea tissues for transplantation. This could, in theory, improve the clinical outcome and 
reduce the complications associated with allogeneic corneal transplants. 
A decellularized tissue provides a three-dimensional ECM structure for corneal 
reconstruction that fully mimics the native tissue and can be applied with or without the 
addition of a cellular component. Corneal decellularization has been performed on 
porcine corneas using various methods: Sodium dodecyl sulfate (SDS) [55], Triton-X 
[56], hypertonic NaCl solution [57, 58], and high hydrostatic pressure [59, 60]. These 
methods have been used by several groups in Asian [55-60], and on bovine corneas by 
our group [61]. There are various results in the literature, however, with some reports 
failing to provide proper quantitative data on the presence of cell debris, which may 
cause immune reactions and affect transparency [62]. The relevance of cell debris can be 
seen in a recent article reporting that both untreated corneas as well as corneas in which 
cell debris was not removed experienced immune rejection in a primate model [58, 62] 
Recently, our group successfully engineered decellularized corneas from both porcine 
and bovine tissue with a novel method, combining chemical and enzymatic treatments to 
remove the cellular components, but also incorporating vitrification and cross-linking 
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steps to improve the optical and structural properties of the device. With this novel 
procedure, we were able to create acellular porcine and bovine corneas containing almost 
no cellular debris, while maintaining impressive light transmission rates and 
biocompatibility. Moreover, the curvature can be manipulated in this novel, engineered 
decellularized cornea, allowing for control of the refractive index, which is essential to 
corneal function. Another promising decellularizing method is gamma-radiation. The 
prosthesis is already on the market, commonly known as the human allogeneic “sterile 
cornea.” A study reported the results of 150 patients who received anterior lamellar 
keratoplasty with this product. They showed high levels of epithelialization within a few 
days and no postoperative infection or rejection in all but four cases, all of which 
occurred in patients with preexisting corneal melting [63]. In addition, we successfully 
characterized this cornea with biological and mechanical methods. The gamma-irradiated 
human cornea shared similar properties with the fresh human cornea. It is suggested that 
the gamma-irradiated human cornea would be a suitable corneal substitute in various 
ophthalmic applications [64]. 
 2. 3. 2. Corneal adhesive 
Some specific ocular injuries or even surgical incisions require highly localized 
tissue repair. Traumatic defects or even cataract incisions would benefit greatly from a 
repair strategy that includes both physical apposition (i.e. tissue bonding) and biological 
stimulation to promote new tissue development. Such technology for local corneal repair 
includes tissue adhesive (TA) biomaterials that can form chemical, biological or physical 
bonds with the molecular residues from local tissue. Before the development of TAs for 
the eye, nylon sutures were the standard method to close corneal wounds caused by 
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cataract incision, corneal ulcer, trauma or transplant [65]. These new materials offer to 
improve on the past regenerative results of sutures for surgical and non-surgical wounds 
by reducing operation time, minimizing scar formation [66] and providing a vehicle for 
delivery of biological signals that can stimulate tissue development.  
Corneal tissue adhesives can be categorized as biologic or synthetic in nature [67]. 
Fibrin glue is a biologic adhesive that is composed of fibrinogen and thrombin [68]. The 
material is prepared by processing plasma from autologous blood or from plasma pools 
of volunteer donations. In corneal surgery, fibrin glue has been employed to seal corneal 
perforations and it melts along with adhering amniotic membrane to the ocular surface. 
The adhesive can also be applied in different kinds of keratoplasty and even to 
temporarily stabilize keratoprosthetics [68]. Fibrin glue is easy to prepare and is highly 
biocompatible. However, as a blood product, it carries the risk of disease transmission 
and its low tensile strength and fast degradation are significant drawbacks [67]. Thus, 
there is a significant need for an ocular adhesive that has the biological benefits and 
compatibility of a biological adhesive but has the increased mechanical strength and 
durability specifically needed for ocular applications. 
Synthetic adhesives provide faster polymerization (i.e. cure rate) and higher 
tensile strength, making them good candidates for corneal wound closure devices. 
Among all of the synthetic adhesives for corneal wound healing, polymeric hydrogels 
have been proven to be the most effective. For example, a dendritic linear copolymer 
based on poly (ethylene glycol) (PEG), glycerol and succinic acid was shown to be 
effective in closing linear, full-thickness corneal incisions [69]. After photo crosslinking 
using UV light, the adhesive produced a firm seal, matching the strength of sutures. In 
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vivo studies of this dendrimeric adhesive have shown no toxicity and good 
biocompatibility [67]. Another version of the material that does not require light has been 
applied clinically in Europe. While these materials have the strength and durability 
required clinically, they have little biological activity to stimulate new tissue growth. 
To create an ocular adhesive that combines the benefits of both synthetic and 
biological materials, a biosynthetic ocular adhesive was engineered in our group. The 
first generation adhesive we developed was composed of a modified chondroitin sulfate 
(CS), CS-aldehyde that, when combined with polyvinyl alcohol co-vinylamine (PVA-A), 
cross-linked together and with the surrounding tissue. The aldehyde-amine reaction 
provided the basis for this adhesive; however, the biocompatibility was not perfect [70]. 
Therefore, we created a second generation material that combines CS and PEG. In this 
case, the CS is modified with succinimide groups and is chemically cross-linked with 
PEG-amine molecules through a Michael Addition [71]. In addition to being more 
biocompatible, the CS-PEG adhesive formed tight seals on corneal incisions to maintain 
a normal intraocular pressure. Ultimately, the combination of the biological benefits of 
the CS, which includes reducing scar formation and inflammation, with the physical 
benefits of the synthetic PEG, which provides durability, allows the creation of an 
optimal ocular tissue adhesive. Drugs, such as antibiotics or anti-inflammatory molecules, 
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3. 1. Introduction 
Due to the development of explosive weapons, the risk and severity of eye 
injuries have been increasing on the battlefield [73, 74]. Although protective goggles help 
to reduce the incidence of eye injuries, ocular trauma comprised approximately 12% and 
5% of injuries in the Persian Gulf War and in the recent Iraqi conflict, respectively [75-
77]. Approximately half of all blast trauma in the recent operation was composed of open 
globe trauma [77], which is characterized by much worse visual outcomes compared to 
closed globe trauma [78]. 
 Prompt surgical closure using sutures is the accepted method of primary repair 
for open globe injuries [75]. However, the technique requires trained ophthalmic 
surgeons, special instruments, a surgical microscope and surgical facilities, all of which 
could be limited in the battlefield. In addition, suture repair is limited for certain injuries, 
for example those associated with significant tissue loss. In such injuries wound 
                                                          
2 Part of this chapter was previously published as a paper here: Chae JJ, Mulreany DG, 
Guo Q, Lu Q, Choi JS, Strehin I, Espinoza FA, Schein O, Trexler MM, Bower KS, 
Elisseeff JH. (2014) “Application of a collagen-based membrane and chondroitin sulfate-
based hydrogel adhesive for the potential repair of severe ocular surface injuries” 





apposition may be inadequate which may in turn lead to serious astigmatism. Moreover, 
critical ophthalmic injuries are usually sustained in conjunction with other life-
threatening damage, such as brain and facial damage [74, 79] that can lead to the delay of 
ophthalmic repair and treatment.  
Ocular adhesives can potentially serve as an initial treatment alternative to 
traditional ophthalmic surgical procedures [80]. Cyanoacrylate and fibrin glue have been 
used clinically. However, the former is toxic, inhibits the epithelial healing process, may 
be easily dislodged and is limited in use to very small penetrating wounds. The latter is 
not strong enough to hold tissue together for repair of open globe injuries and has a high 
risk of secondary infection by bacteria and fungi [67, 81]. Several other biological and 
synthetic adhesives as well as laser welding are under development [82-84]. However, 
these approaches have limitations, including complex application methods, additional 
required instruments, reduced adhesive coverage and a narrow range of treatable wound 
types. 
Our group has developed an adhesive hydrogel composed of chondroitin sulfate–
polyethylene glycol (CS-PEG) and a collagen vitrigel (CV) membrane that can serve as a 
biological bandage or an eye patch. Previous studies have shown that the CS-PEG 
adhesive is nontoxic, transparent, flexible, hydrophilic, and can incorporate drug delivery 
systems [85], making it ideal for use in the eye [71].  When compared to conventional 
ophthalmic adhesives, the CS-PEG adhesive demonstrated its superior biocompatibility 
and mechanical properties [86]. Furthermore, those merits were confirmed by the porcine 
partial keratectomy model [71]. CV is a thin, transparent, and flexible membrane 
produced by the vitrification of a traditional collagen hydrogel [87]. Previous studies 
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have shown the membrane has excellent mechanical and biological properties to support 
the three types of corneal cells as a biomaterial [51, 88]. In addition, our recent data 
indicated the membrane could support the regeneration of corneal epithelium and stroma.  
The main purpose of this study is to evaluate the potential of CS-PEG + CV as a 
method to repair blast injuries which cause open globe injuries using a cadaver model. In 
addition, cornea shaped CV was developed to facilitate CV application by matching the 
eye contour and antibiotic release was incorporated in the CS-PEG adhesive to prevent 
potential infections.  
 
3. 2. Materials & Methods  
3. 2. 1. Synthesis of flat and curved collagen vitrigels  
Collagen vitrigels (CVs) were fabricated using a modified method from a 
previous publication [51]. Briefly, 0.5% collagen type I solution (AteloCell, Koken, 
Tokyo, Japan) and culture media composed of Dulbecco’s modified Eagle’s medium, 10% 
fetal bovine serum, 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid and 1% 
penn-streptomycin solution were uniformly mixed in a 1:1 (v/v) ratio. 5 ml of the 
solution was incubated at 37 °C to produce a gel; this gel underwent a vitrification 
process at 10 °C and 40% of humidity. Finally, the material was rehydrated with 
phosphate buffered saline (PBS) to form a thin, transparent, flexible collagen membrane. 
Generally, flat CV is referred to as CV for short, unless otherwise specified. 
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To enhance the handling convenience of CV, a curved CV was developed. The 
first two steps were the same as those for traditional, flat CV as mentioned above except 
that a concave mold assembled in a glass chamber with a small opening, instead of 
culture dishes, was utilized for curved CV (Figure 3.1A). After gelation, the slow 
vitrification was first introduced to the gelled collagen in the assembled mold in the same 
incubation condition for 24 hours. Fast vitrification of the collagen gel was then carried 
out for two weeks by disassembling the glass chamber from the concave mold (Figure 
3.1B). As with flat CV, the curved CV was rehydrated before applying on the corneas 
(Figure 3.1C).  
3. 2. 2. Chondroitin sulfate - succinimidyl succinate synthesis and adhesive preparation 
The formation of CS-PEG adhesive was achieved by reacting CS-succinimidyl 
succinate (CS-NHS) with 6-arm poly(ethylene glycol)-amine (PEG-(NH2)6, 20.0 kDa, 
SunBio, Ansan, South Korea). Synthesis of CS-succinimidyl succinate (CS–NHS) was 
carried out as described previously [86]. Briefly, 10%, 25% and 67% (w/v) PBS solution 
of CS (chondroitin sulfate A, 25.0 kDa, New Zealand Pharmaceuticals Ltd, Palmerston 
North, NZ), N-hydroxysuccinimide (NHS) (Thermo Fisher Scientific, Rockford, IL), and 
N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC, Sigma-Aldrich, 
St. Louis, MO) were combined in a v/v ratio of 6.0:1.5:1.5  and left to react for 10 min at 
37 °C. The resulting mixture was frozen and extracted with -20 °C ethanol. Precipitated 
CS-NHS was then washed nine times with ethanol and dried under high vacuum 
overnight. The prepared CS-NHS and PEG-(NH2)6 were both dissolved in the PBS and 
HEPES buffer to a final concentration of 20% (w/v). The two components were chilled 
26 
 
on ice for 5~30 minutes and then mixed at a 1:1 (v/v) ratio. The mixed adhesive was 
immediately applied to the ocular surface. 
3. 2. 3. Repair of porcine cadaver model for battlefield injuries and burst test 
A porcine cadaver eye model was used to simulate linear and circular open 
wounds in corneal, corneoscleral and scleral regions of the eye. Fresh porcine eyes were 
obtained from a local abattoir. A type of full thickness injury was made in each eye to 
mimic open globe injuries: a linear laceration or a circular penetrating wounds 
representing without or with loss of tissue, respectively. Linear wounds were made by 
inserting various types of scalpel blades perpendicular to the tissue (Figure 3.1D). In case 
of a larger wound which could not be made by only inserting scalpels, the wounds were 
made by inserting the scalpel and then slicing across the tissue until the desired length 
was achieved. Each linear laceration was measured to confirm the desired dimensions 
before beginning the repair by ophthalmic caliper. Due to the size limitation of porcine 
eye, the maximum length of linear laceration in the corneal and corneoscleral areas were 
set at 16mm and 22mm, respectively, based on references [89, 90]. Circular penetrating 
wounds were made by inserting a trephine through the tissue perpendicularly. These 
wounds were made in different sites, including corneal, scleral and corneoscleral regions.   
The damaged porcine globes were repaired via one of three treatment modalities: 
traditional suture closure, CS-PEG adhesive-only, or CS-PEG adhesive + CV membrane. 
All suture repairs were performed by a surgeon (JJC) using 10-0 nylon sutures for corneal 
repairs and 8-0 nylon sutures for corneoscleral and scleral repairs, as per routine primary 
repair on the battlefield [78]. Sutures were not applied in the case of circular wounds 
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since such wounds cannot be closed by primary apposition. Repairs using CS-PEG 
adhesive were made by applying the adhesive directly to the wound using the pipette 
(Figure 3.1E). The surface of the eye around the defect site was dried to get the maximal 
effect of the adhesive using ophthalmic sponges prior to adhesive application. The 
volume of adhesive applied to the eye ranged from 30 to 200 µl depending on the size of 
the defect. Repairs made using both the adhesive and CV membrane were performed in a 
similar fashion to adhesive-only repairs, except after applying the adhesive, the 
rehydrated CV membrane was placed over the defect and spread out to remove any 
wrinkles and assure CV adhesion to the CS-PEG adhesive (Figure 3.1F). 
For each tissue, wound and treatment type, repairs on increasing defect sizes were 
conducted until the critical size was reached. A successful repair was defined as a sealed 
defect that allowed pressurization of the eye to 35 mmHg or greater. Each wound was 
determined as repairable if it could be successfully repaired three times in a row or four 
times within five trials.   The eyes were pressurized via a 25 gauge needle inserted 
through the limbus into the anterior chamber. A syringe pump injected balanced salt 
solution (BSS) into the anterior chamber of the repaired eyes at a fixed rate of 20 ml/hr. 
A digital manometer (DigiMano 1000, Netech Systems, Farmingdale, NY) was placed in 
line with the pump. The manometer was monitored until the intraocular pressure reached 
35 mmHg, at which point the syringe pump was stopped and the wound was assessed to 
determine whether there was leakage of fluid on the ocular surface (Figure 3.1G).   
3. 2. 4. In vitro antibiotic release test and Kirby-Bauer bacterial inhibition test  
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  To calculate the release kinetics, an antibiotic release test was conducted. CS-
PEG adhesive hydrogels were made using a cylindrical mold (100 μL, 4.0 mm thickness 
 6.0 mm diameter).  Either 2% of vancomycin hydrochloride (V-HCl, Sigma-Aldrich, St. 
Louise, MO) or vancomycin free base (V-FB) was encapsulated into the CS-PEG 
adhesive as previously described [91]. Each cylinder shape adhesive was immersed by 1 
ml PBS in a 24-well tissue culture plated and then incubated at 37 C for performing the 
release study. Three replicates were used in each condition. PBS fractions were collected 
at various time points up to three weeks and the concentration of vancomycin in each 
fraction was analyzed using high performance liquid chromatography (HPLC) with an 
analytical column (XTerra RP18, Waters, Milford, MA). 
  The Kirby-Bauer bacterial inhibition (KBBI) test was performed to analyze the 
potency of the antibacterial effect of vancomycin. Cylindrical CS-PEG adhesives (20 L, 
2.0 mm thickness × 3.6 mm diameter) were made with 2% antibiotics (V-HCl or V-FB) 
as mentioned above. The adhesive masses were put on PBS for time periods ranging from 
0~6 days and then placed on the culture dishes uniformly covered with Staphylococcus 
aureus (S. aureus, MicroBiologics, St. Cloud, MN) and Lysogeny broth agar (Sigma-
Aldrich). Five replicates were made for each time point and condition. The plates were 
incubated at 37 C for 24 hours and the zone of inhibition (ZOI) around each hydrogel 
was measured (Figure 3.1H). The areas of ZOI were analyzed by the Mann-Whitney test 
to evaluate the differences between two groups at each time point. Statistical significance 
was established at p-values < 0.05. 
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3. 2. 5. Cadaver and in vivo application of cornea shaped collagen vitrigel in the 
rabbit model  
 To check the usability of curved CV, four rabbit cadaver eyes (Pel-Freez 
Biologicals, Rogers, AR) were used. Both curved and flat CVs were examined by placing 
them on top of the cadaver eyes or inserted into the corneal pockets. Cornea pockets were 
created using an ophthalmic crescent knife (Laseredge, Bausch&Lomb, Rochester, NY), 
and then either flat or curved CV was inserted into the cornea with 20 μl of CS-PEG 
adhesive on both sides. To improve visibility, CVs were stained by trypan blue (trypan 
blue stain 0.4%, Gibco, Grand Island, NY) before applying it. A routine cryosection was 
performed for making slides which were subsequently stained with hematoxylin and 
eosin (H&E). Following the in vitro cadaver work, an in vivo study was performed. All 
animals (n = 2) were treated under the approval of the Animal Care and Use Committee 
at Johns Hopkins University and the ARVO Statement for the Use of Animals in 
Ophthalmic and Vision Research. Curved and flat CVs were tested and compared using 
two male New Zealand White rabbits weighing 3.5 kg. Superficial keratectomy was 
performed using 8 mm Hessburg-Barron vacuum trephine and an ophthalmic crescent 
knife. After applying 20 μl of CS-PEG adhesive, the corneas were covered with either a 
curved or flat CV (8 mm diameter). 
 
3. 3. Results 
3. 3. 1. Repair of porcine cadaver model for battlefield injuries and burst test 
30 
 
Combat-related ocular wounds treated and photographed at the Walter Reed 
Medical Center were modeled in cadaveric eyes (Figure 3.2). The application of adhesive 
generally created a smooth and raised cap of hydrogel above the injury, except in cases 
when excessive moisture, which impeded the attachment of the adhesive, was still present 
on the eye. In contrast to adhesive alone, the CS-PEG + CV treatment conformed to the 
shape of the eye, creating a smooth surface. The CS-PEG adhesive + CV maintained 
sufficient transparency to observe the wound.  
 CS-PEG + CV and suture methods were able to repair the maximum size 
laceration wounds that we could make in both corneal (16 mm) and corneoscleral (22 mm) 
regions, whereas CS-PEG alone could only repair wounds as long as 5 mm in the corneal 
region and 6 mm in the corneoscleral regions (Figure 3.3A). In our experimental model, 
we found the linear injury model in the scleral region rarely leaked at the pressure of 
repair criteria due to the self-sealing by thick vitreous humor. For this reason, we 
excluded the linear sclera wounds in this study. On the other hand, the CS-PEG adhesive 
was also able to repair 3 mm diameter circular wounds in the cornea and 4 mm diameter 
wounds in the corneoscleral and scleral regions. By adding the CV membrane to the 
adhesive, we were able to repair the wounds of approximately double that diameter: 6 
mm in the cornea and corneoscleral regions and 8 mm in the scleral region (Figure 3.3B).  
3. 3. 2. Release and potency of CS-PEG adhesive encapsulated antibiotics  
Release kinetics of two vancomycin forms (V-FB and V-HCl) in the CS-PEG 
adhesives were investigated (Figure 3.4A and B).  In the cumulative release, the 
encapsulated V-HCl had a burst release where almost 60% of the total amount was 
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released.  On the other hand, the amount of released V-FB (about 40%) was less than that 
of V-HCl after the first 5 hours. By the end of three days (72 hours), V-HCl and V-FB 
had released approximately 93% and 88% of their total loading amount, respectively. 
Although both forms started with the same amount of antibiotics, the V-FB release 
showed lower burst and more sustained release compared to V-HCl in the whole release 
period (Figure 3.4A). The daily amount of vancomycin released during the first nine days 
was above the minimum inhibitory concentration (MIC) in both the encapsulated V-FB 
and V-HCl forms. The encapsulated V-FB form released more than that of V-HCl during 
the experiments (Figure 3.4B).  
The activity of antibiotics released from the adhesives was evaluated using the 
KBBI test.  Due to the effect of burst release, V-HCl (8.6 mm) loaded CS-PEG adhesive 
significantly inhibited a larger area of bacteria than that of V-FB (7.6 mm) loaded 
adhesive. However, the size of ZOI turned around at 3 day time point; the radius of ZOI 
by V-FB capsulated adhesive was significantly larger than that of V-HCl capsulated CS-
PEG at the 4 day time point.  Even though the radius of ZOI was getting smaller, it could 
still get up to 3~4 mm by the final day of experiment (Figure 3.4C).   
3. 3. 3. Applicability of cornea shaped collagen vitrigel patches 
Using novel methods, a new CV was created with a controlled three-dimensional 
curvature relevant to the eye (Figure 3.5A). Compared to a flat CV, the curved CV 
improved the applicability. The curved CV showed a self-supporting capability (Figure 3. 
5A) which facilitated the membrane handling compared to the flat CV when implanting 
in cadaveric eyes (Figures 3.5B-D). The three-dimensional shape of the curved CV 
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matched the corneal contour precisely, allowing extensive host-graft integration over a 
large area without any wrinkle formation due to unmatched curvature which had been 
observed with the flat CV. As shown in Figures 3.5E and F, the histological results 
further confirmed the integration of the curved CV in the lamellar corneal pocket. The 
applicability of curved CV was also confirmed in vivo (Figure 3.5G). Due to the matched 
curvature to the eye by the curved CV, the CS-PEG adhesive was able to be applied to 
the eye more uniformly and showed an enhanced attachment of the collagen membrane to 
the eye surface, compared to the flat CV which usually experiences large wrinkles.  
 
3. 4. Discussion 
In this study, we demonstrated that the combination of CS-PEG and CV has the 
potential to repair the types of open globe injuries which threat to vision on the battlefield. 
In previous retrospective studies, corneal abrasion and laceration were the most common 
injuries, accounting for more than one fourth of total eye injuries [92]. During OIF/OEF, 
the length distribution of reported corneal lacerations was from 0.5 mm to 12 mm, with a 
mean value of 3.7 mm [93]. Although the CS-PEG alone method has limitations in 
repairing the largest-sized wounds, it could potentially seal the majority of corneal 
laceration wounds on the battlefield as it can successfully repair wounds of up to 5~6 mm 
in length in the corneal and corneoscleral regions. In addition, the adhesive could help to 
prevent secondary injuries by additional applied force from outside since it can support 
the cornea by sealing the leakage of linear wounds. In the corneoscleral repair, CS-PEG 
alone is not adequate to repair the larger corneoscleral wounds (mean length 8.7 mm) 
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encountered in the Iraqi conflicts [93]. As results shown, the limitations of using CS-PEG 
alone for the large linear wounds found in war could be overcome by using it in 
combination with CV. The CS-PEG + CV method, as tested in our model, can 
successfully repair the maximum-sized injury in both corneal and corneoscleral regions. 
Since the sharp linear wounds created in the sclera were self-sealing, repair of linear 
scleral lacerations was not investigated. Yet, the performance of the CV and adhesive in 
the treatment of round scleral wounds and linear corneoscleral wounds suggests that CS-
PEG + CV should be capable of adequately sealing the majority of scleral wounds 
encountered on the battlefield.  
Approximately 30% of lacerations are not linear but are either stellate or round 
and accompanied by tissue loss. Although CS-PEG alone could not seal the large wounds 
adequately [94], the addition of the CV membrane contributed substantially to a more 
robust repair. After adding CV membrane, the reparable defect size was markedly greater 
than that of CS-PEG alone. When repairing wounds with adhesive alone, it was necessary 
to use enough adhesive to create a hydrogel “cap” over the wound to provide sufficient 
strength for the repair. The protruding cap could irritate the palpebral conjunctiva and 
wear down with friction. The CV membranes provided a structural rigidity to the repair 
and reduced the amount of adhesive needed to seal the wound. By reducing the amount of 
adhesive, the CV membrane could minimize the potential interference of the CS-PEG 
hydrogel bump with the eyelid. 
Clinically, penetrating wounds have to be treated in a timely manner because such 
injuries increase the risk of endophthalmitis, tissue necrosis and deformation of eye [95]. 
Due to the specific limiting conditions of the battlefield, those types of wounds were 
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associated with very poor outcomes [93]. Conventional suturing is the gold standard for 
repairing penetrated ocular injuries, except where the amount of tissue loss prevents 
adequate apposition or where too much irregular astigmatism would be generated. Tissue 
adhesives could be an alternative method to seal defects in the ocular surface. However, 
this method has so far been limited to relatively small diameter wounds (≤ 2 mm) [94]. 
Penetrating keratoplasty, conjunctival flap or patch graft is recommended for relatively 
large penetrating wounds [95]. However, including suture closure, these methods are only 
useful under trained ophthalmologists and surgical team with ophthalmic instruments and 
an equipped operating room. Recently proposed methods with adhesive and various 
patches such as amniotic membrane, absorbable fibrin sealant patch, and tectonic drapes 
have been developed to treat larger penetrating wounds. However, those materials only 
can treat wounds less than 5 mm in diameter [96-100]. The CS-PEG and CV are 
promising materials in the battlefield since the combination of these two materials could 
potentially be used to treat larger size wounds without reliance on a fully equipped 
microsurgical operating room. In addition, another benefit of these materials is their 
transparency that allows subsequent care providers to examine the injuries without 
removing materials. 
The severe wounds encountered with military injuries have high rates of 
contamination and subsequent infection. Incorporating antibiotic with the CS-PEG 
adhesive has the potential to reduce the incidence of infection through the application of a 
controlled release of bioactive antibiotics for several days. Vancomycin is a widely used 
antibiotic for treating  injuries of eye [95].  Based on the results, CS adhesive with V-FB 
is superior to the V-HCl form considering the sustainability of the releasing kinetics and 
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inhibition of bacteria. By converting V-HCl into V-FB, we profoundly decreased the 
water solubility (from 200 mg/ml to 20 mg/ml) of vancomycin and increased its 
hydrophobicity [91], which is essential for controlled release in a hydrophilic 
environment such as CS-PEG tissue adhesive. Consequently, V-HCl embedded adhesive 
had a high burst release initially, while the V-FB form released a significantly reduced 
amount followed by a more controlled release. Moreover, both forms were able to release 
higher than MIC which could inhibit the growth of bacteria for nine days. We believe that 
the release time of vancomycin is enough to cover the time for evacuation of the 
wounded solder to a hospital where definitive medical and surgical treatment can be 
offered.  
CV is a biosynthesized acellular membrane with a distinctive advantage of being 
able to form customized three-dimensional shapes by modifying the processing method. 
While the flat CV membrane generally conforms well to the curvature of the eye 
occasionally some wrinkles form at its edges during application. We speculate that these 
wrinkles may weaken the seal and potentially impede epithelial healing. The performance 
of the CVs was improved by using curved CVs with a shape that conforms to the natural 
curvature of eye.  
We have demonstrated, in a porcine cadaver model, the potential suitability of 
CS-PEG + CV   to provide sufficient mechanical strength to treat most battlefield ocular 
injuries. However, additional challenges need to be overcome to create a viable product 
for use on the battlefield and in the clinic. These include the requirement for stable long-
term storage of the adhesive in a usable form that would be ready on demand, and the 
availability of CVs in a variety of basic sizes and configurations.  
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Although we demonstrated that the combination of CS-PEG adhesive + CV as a 
promising method to treat severe ocular traumas, there are additional limitations to 
creating a viable product for use on the battlefield and in the clinic.  The adhesive and 
patch require stable long term storage in a usable form that would be ready on demand 
and CVs are needed in a variety of basic sizes and configurations. Additionally, the 
gelation time of CS-PEG adhesive is significantly decreased in temperatures exceeding 
35 °C16. Some operations in high temperature situations may decrease application time 
by approximately one minute after its preparation. If the CS-PEG + CV is to be used in a 
high temperature environment, reasonable cooling methods need to be developed. 
 
3. 5. Conclusion 
The combination of CS-PEG adhesive and CV membrane demonstrated potential 
for repairing penetrating ocular injuries on the battlefield. In addition, incorporation of 
antibiotic release functionality and modification of the curvature of the collagen 
membranes were accomplished to further improve the applicability of those materials for 






Figure 3. 1. Curved vitrigel preparation procedures, wound repair model and burst 
test, and KBBI test. After mixing the collagen solution with the proper media, the 
process of gelation (A) and fast vitrification (B) were followed in the curved mold. 
Rehydration using PBS buffer was performed prior to application to the eye (C). A defect 
was made in enucleated porcine eyes via scalpel or trephine (D), followed by application 
of CS-PEG adhesive to the wound and surrounding tissue using a conventional pipette 
(E). In the case of CV and CS-PEG adhesive repairs, the CV was applied to the wound 
area with forceps after adhesive application (F). After allowing the CS-PEG to firm up 
for approximately 15 minutes, a needle was inserted through the limbus into the anterior 
chamber and the intraocular pressure was increased through use of a syringe pump until 
the intraocular pressure reached 35 mmHg. If there was no leakage, the corneal wound 
was considered to be repaired (G). After creating vancomycin encapsulated in CS-PEG 
columns and soaking them in PBS buffer, the columns were placed on a Petri-dish 
uniformly covered with Staphylococcus aureus (S. aureus, MicroBiologics, St. Cloud, 




Figure 3. 2. The representative combat injuries on the ocular surface and their 
repair by suture, CS-PEG + CV and CS-PEG adhesive in a porcine eye model. CS-
PEG adhesive + CV can effectively repair the various types of wounds without 
deformation of the eye. In addition, they can be applied to large, circular wounds that can 





Figure 3. 3. Maximum reparable wound size depended on the method of treatment 
and characteristics of the wound: in linear and round types of defects. Conventional 
suture and CS-PEG + CV treatment can repair the same maximum size of wounds in 
linear types of defects on both corneal and corneoscleral surfaces (A). The addition of the 
CV membrane enabled the repair of larger wounds than CS-PEG adhesive alone. The 
reparable defect size using CS-PEG + CV was markedly greater than that of CS-PEG 










Figure 3. 4. Vancomycin release kinetics and zones of inhibition measured for 
vancomycin released with encapsulated vancomycin hydrochloride (V-HCl) and 
vancomycin free base (V-FB).  Cumulative release of vancomycin in CS-PEG adhesive 
showed V-FB had a more sustained release than V-HCl (A). The daily release amounts of 
the two forms of vancomycin in CS-PEG adhesive demonstrated both forms of 
vancomycin could be released above the MIC for up to nine days (B). A KBBI test of the 
antibiotics released confirmed the released antibiotics efficiently inhibit the growth of 
bacteria up to seven days and that encapsulated V-FB are more efficiently controlled than 
encapsulated V-HCl (C). *: Statistical significance was established by Mann-Whiney test 
at p < 0.05.  
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Figure 3. 5. An external view of curved collagen vitrigel (CV) with blue dye, and a 
comparison between curved and flat collagen vitrigels on rabbit eyes.  A 
representative photograph of the curved CV stored in PBS buffer (A). Flat and curved 
CV applied to the rabbit cornea: on the cornea (B) and in the lamellar corneal pocket (C). 
The images of CVs on the ocular cross-section (D), in the lamellar corneal pocket with 
H&E staining (E-F) and on live rabbit corneas affixing by CS-PEG bioadhesive (G) 
showed the superior attachment of the curved CV which did not cause wrinkles on the 












4. 1. Introduction 
Corneal disease is the fourth leading cause of blindness worldwide [101]. Many 
of these cases could be cured by allogeneic corneal transplantation, one of the most 
common and successful tissue transplantation procedures [63]. However, there are 
obstacles to corneal transplantation, including insufficient quality and quantity of donors, 
a short viable timeframe between donation and transplantation, contamination by bacteria 
and fungi during donor preparation, and the possibility of disease transmission [63, 102, 
103].  In addition, conventional corneal transplantation has a high failure rate in high-risk 
populations due to immune rejection or mechanical graft failure [102]. 
The gamma-irradiated human cornea (VisionGraft
®
, Tissue Banks International, 
Baltimore, MD) may help to alleviate such problems. Donor corneas unsuitable for 
transplantation, typically due to low endothelium quality, become commercial gamma-
irradiated corneas though cryogenic treatment and approximately 17-23 kGy of gamma 
irradiation from a cobalt-60 source. Those processes extend shelf life, expanding the pool 
of potential donor corneas.  Another benefit to using the gamma-irradiated cornea is the 
                                                          
3 Part of this chapter was previously published as a paper here: Chae JJ, Choi JS, Lee JD, 
Lu Q, Stark WJ, Kuo IC, Elisseeff JH. (2015). “Physical and Biological Characterization 




reduction of disease transmission risk and microbial contamination during donor 
preparation. Third, the gamma-irradiated cornea can potentially be transplanted in 
populations at high risk of immune rejection when using conventional human corneas [63, 
104, 105]. Despite the fact that the gamma-irradiated cornea cannot be used for full-
thickness corneal transplantation, it can be used for lamellar keratoplasty (which does not 
require viable endothelial cells) and for corneal patch grafts [105]. In addition to 
applications in corneal surgery, this tissue can be used to cover glaucoma tube shunts and 
act as the skirt of the keratoprosthesis [63]. To accommodate the surgeon’s preferences, 
these corneas can also be provided in various shapes and sizes with full- or partial-
thickness stromas.   
Gamma irradiation of donor corneas, however, may alter the structure of corneal 
extracellular matrix (ECM) and change its physical and biological properties, which 
would in turn affect cornea physiology and limit its surgical utility.  The effect of gamma 
irradiation has been studied on various tissues. Although there were no significant 
changes after applying a low dose (2-10 kGy) of gamma irradiation in the Achilles 
tendon [106], most studies have indicated that gamma irradiation induces substantial 
physical and/or biological alterations with structural changes [107-111]. The structural 
alterations include inter- and intra-collagen crosslinking, collagen molecular 
fragmentation or degradation by polypeptide chain scission, and collagen fibril 
reorganization [111-114]. Because collagen is the main component of corneal proteins 
[115], gamma irradiation could be expected to biologically and physically alter the 
corneal ECM. In addition, altered physical and biological properties influence the 
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reconstruction process of the cornea and surgical manipulation such as handling and 
suturing the donor tissue.   
Although the gamma-irradiated cornea has been used successfully in clinical 
situations and its popularity is rising, there is limited information about its optical 
properties and structure, especially compared with fresh donor corneas [116, 117]. 
Therefore, the purpose of this study was to characterize physical and biological properties 
of the commercial gamma-irradiated cornea, to determine if it is a viable surgical material. 
 
4. 2. Materials & Methods 
4. 2. 1. Corneas 
 Gamma-irradiated human corneas were donated by Tissue Banks International 
(Baltimore, MD). Human corneas were handled according to the Declaration of Helsinki, 
and the study was approved by Johns Hopkins Medicine Institutional Review Boards. A 
total of 28 fresh and 25 gamma-irradiated corneas (within expiration date) were used in 
this experiment. The average age of donor, average days in storage, and average 
preservation time were 52.9 ± 15.8 years (range, 18~74 years), 8.8 ± 4.4 days (range, 1 ~ 
13 days), and 12.5 ± 5.1 hours (range, 3 ~ 22.7 hours), respectively. As a negative control, 
to emulate a degrading tissue matrix, six gamma-irradiated corneas that were more than 
two years past the manufacturer’s expiration date (“outdate gamma-irradiated corneas”) 
were evaluated for the characteristics of light transmittance, compressive modulus, and 
hydration. The term ‘gamma-irradiated cornea’ indicates a cornea within its expiration 
date. Fresh corneas were preserved in Optisol GS (Bausch & Lomb, Rochester, NY) at 2–
45 
 
8 °C and gamma-irradiated corneas were stored in hyperosmolar albumin-based media at 
room temperature. All samples were prepared by removing the scleral rim and epithelium 
using conventional ophthalmic scissors and a #15 blade before performing experiments.  
4. 2. 2. Light transmittance 
 Five full-sized, fresh and gamma-irradiated corneas, and three full-sized outdated 
gamma-irradiated corneas were cut with a 10-mm trephine. Each cornea was washed 3 
times using balanced buffer solution (BSS) and placed on a 48-well microplate. Using a 
multimode microplate reader (Synergy 2, Biotek, Seattle, WA), the blank-corrected light 
absorbance of each cornea was measured in 10-nm increments over the full visible 
spectrum (400 to 700 nm). The light transmittance was derived by the Beer-Lambert law 
with the equation, transmittance (%) = e-absorbance x 100.  
4. 2. 3. Compressive modulus 
 Immediately after measuring light transmittance, the same corneas were used for 
measuring compressive modulus. Compression was applied to the full-sized sample from 
0% to 10% thickness of the cornea using an Electroforce 3200 testing instrument (Bose, 
Eden Prairie, MN) with a 250-g load cell at room temperature. The modulus was 
calculated using a computer program (MATLAB, MathWorks, Natick, MA) to find the 
slope of the best fit curve with a linear region of stress versus strain plot, as performed 
previously [86].   
4. 2. 4. Hydration 
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 Swelling ratio (wet mass / dry mass) was determined as follows: five half-sized, fresh 
and gamma-irradiated corneas and three half-sized, outdated gamma-irradiated corneas 
were immersed in a sealed conical tube containing 10 mL of BSS and incubated at 37°C 
for 24 h. After 24 h, the swollen corneas were weighed after removing excess BSS using 
filter paper and a digital balance (XS 105, Mettler toledo, Columbus, OH).  The samples 
were then lyophilized for 72 hours and weighed to obtain the dry mass.  
4. 2. 5. Thermal properties 
 The thermal properties of each cornea, collected from both the central and peripheral 
areas, were characterized using differential scanning calorimetry [DSC (DSC 8000, 
PerkinElmer, Norwalk, CT)] as described previously [88]. Using a 4-mm trephine, 
samples approximately 20-mg in mass were collected from five full-sized, fresh and 
gamma-irradiated corneas. One sample was taken from the central cornea and 4 buttons 
were excised from the peripheral region. The specimens were sealed in a 30-μL 
aluminum pan to prevent evaporation of the water content; an empty sealed pan was used 
as a reference.  At a rate of 5°C/min, the samples were cooled from room temperature to -
30°C under nitrogen flow, and then heated to 90°C. A set of cooling and heating was 
repeated. The thermograms were analyzed and the denaturation temperature was 
determined using the Pyris series software (PerkinElmer, Norwalk, CT). Denaturation 
temperatures of each cornea were analyzed regardless of location to determine whether 
there were any differences between fresh and gamma-irradiated corneas. The geometric 
effect on denaturation temperature was then evaluated by comparing the central and 
peripheral regions of each cornea.  
47 
 
4. 2. 6. Structural assessment 
 Five half-sized, fresh and gamma-irradiated corneas were used to access corneal 
structure.  After removing central and peripheral portions of the cornea using 1.5- and 4-
mm trephines, each specimen was collected for microstructural assessment using a 3-mm 
trephine. Other portions of the cornea were used for evaluating corneal macrostructure. 
Both fresh and gamma-irradiated corneas were dehydrated, embedded in paraffin and 
stained with hematoxylin and eosin (H&E) using standard techniques. For transmission 
electron microscopy (TEM), the central part of corneas was fixed using a solution of 3% 
paraformaldehyde, 1.5% glutaraldehyde, 5 mM MgCl2, 5 mM CaCl2, 2.5% sucrose, and 
0.1% tannic acid in 0.1 M sodium cacodylate buffer at pH 7.2 overnight in a cold room. 
After a PBS buffer rinse, the samples were stained with 1% osmium tetroxide on ice for 1 
hour, rinsed in deionized water, and stained en block overnight in Kellenberger uranyl 
acetate. Following dehydration with a graded series (75%, 95%, and 100%) of chilled 
ethanol solutions, the samples were embedded in EPON resin (Eponate 12, Ted Pella, 
Redding, CA) at 60⁰C for 60 to 96 hours. The embedded samples were sectioned using 
an ultramicrotome (Ultracut UCT, Leica, Wien, Austria), collected on grids, and stained 
with uranyl acetate. The samples were examined and electronic digital pictures were 
taken using a TEM (Philips 420, FEI Co., Hillsboro, OR) system at 80 kV. Images were 
taken at depths between 20 and 80% of full corneal thickness. After pictures were 
converted to TIF files, ten TEM images in each cornea were magnified approximately 
100,000-fold. Five areas were randomly chosen in each picture, and areas were defined as 
1  1 µm
2
. The collagen fibrils within the square were manually counted by masked 
48 
 
observers, and the numbers of collagen fibrils were presented per µm
2
, as demonstrated 
previously [118].   
4. 2. 7. DNA content 
 The DNA content of each cornea was determined using Hoechst 33258 dye (Molecular 
Probes, Eugene, OR) as described previously [119]. Briefly, lyophilized corneas for the 
hydration test were digested in a 125-µg/mL papain solution (Worthington, Lakewood, 
NJ) for 16 hours at 60 °C, and the fluorescent intensity of a mixture of 30-µL papain 
digestion and 1 µg/mL of Hoechst dye in TNE buffer was measured using a fluorometer 
(DyNA Quant 200, Hoefer, Holliston, MA). The DNA content was calculated from a 
standard curve generated using calf thymus DNA. 
4. 2. 8. Human corneal epithelial cell proliferation test 
 Fresh human corneas not used in the characterization were treated with 1.2 U/ml of 
dispase II (Roche Diagnostics, Mannheim, Germany) in the Epilife
®
 medium (Invitrogen 
/ Life Technologies, Grand Island, NY) at 4°C for 16 hours. Under a dissection 
microscope, epithelial sheets were collected and incubated in the 0.05% trypsin-EDTA 
solution at 37°C for 30 minutes. After vigorous pipetting and neutralizing trypsin-EDTA, 
primary cells were cryopreserved at -120°C for preparation for the proliferation assay. To 
evaluate the proliferation of human corneal epithelial cells (hCECs) on corneas and tissue 
culture plates (TCPs), a 48-well microplate was prepared. Each of 16 TCP wells was 
either covered by approximately 100-µm thick fresh or gamma-irradiated cornea or left 
untreated. hCECs were thawed in a 37°C water bath and subcultured in the Epilife 
medium with the Human cornea growth supplement (HCGS, Invitrogen/Life 
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Technologies, Grand Island, NY) and 2.5 ng/ml epithelial growth factor (EGF, Upstate 




 until confluent. After 
detaching confluent hCECs using 0.05% trypsin-EDTA, the cells were seeded on the 
microplate with a density of 1.0  10
4
 per well. At 0, 5, 14, and 21 days after seeding 
cells, the number of hCECs was measured in 4 wells of each of the three groups using the 
cell counting kit-8 CCK-8 (Dojindo Molecular Technology, Inc., Rockville, MD) 
following manufacturer instructions. The absorbance, correlated with the number of cells, 
was measured using a multimode microplate reader (Synergy 2, Biotek, Seattle, WA) at 
450 nm.  
4. 2. 9. Statistical analysis 
 Data are displayed as means ± standard deviation (S.D.). Results were analyzed by the 
Mann-Whitney test, Student’s t-test or Spearman's rank correlation, depending on the size 
and character of samples. Statistical analyses were performed using SPSS 15.0 for 
Windows (SPSS Inc., Chicago, IL). Statistical significance was established at p < 0.05.  
 
4. 3. Results 
4. 3. 1. Light transmittance, compressive modulus and hydration  
Transparency—the main characteristic of a cornea—elasticity (compressive 
modulus), and crosslinking density (swelling) were measured in three different corneas: 
fresh, gamma-irradiated, and outdated gamma-irradiated. There was no significant 
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difference between gamma-irradiated corneas and fresh corneas in transparency, elastic 
modulus, or crosslinking density (Figure 4.1).   
To quantify transparency, we measured the transmittance of visible wavelength. 
Although the transmittance of visible light through gamma-irradiated cornea was slightly 
greater than that of the fresh corneas, the difference was not statistically significant. 
However, the light transmittance of the gamma-irradiated cornea was significantly 
greater than that of the outdated gamma-irradiated cornea from 400 to 540 nm (Figure 
4.1A). The compressive modulus was measured by indentation. There was no difference 
in the elasticity between fresh corneas (24.4 ± 6.4 kPa) and gamma-irradiated corneas 
(25.1 ± 5.8 kPa, p = 0.452). However, the elastic modulus of outdated gamma-irradiated 
corneas (7.5 ± 2.5 kPa) was significantly lower than that of gamma-irradiated corneas (p 
= 0.036, Figure 4.1B).  
Hydration (swelling ratio; wet weight/dry weight) was measured to assess the 
crosslinking density of the corneas. Wet masses of fresh, gamma-irradiated and outdated 
gamma-irradiated corneas were 97.58 ± 6.59, 96.18 ± 10.91 and 108.67 ± 3.60 mg, 
respectively. After lyophilization, the dry masses of fresh, gamma-irradiated and outdated 
gamma-irradiated corneas were measured as 13.98 ± 1.17, 14.3 ± 1.79, and 14.4 ± 0.72 
mg, respectively. The dry masses between the different corneas were statistically similar 
(p > 0.750). There was no difference in swelling ratio between gamma-irradiated corneas 
(6.98 ± 0.16) and fresh corneas (6.73 ± 0.17, p = 0.096, Figure 4.1C). Outdated gamma-
irradiated corneas, however, had a significantly larger swelling ratio (7.56 ± 0.40) 
compared to that of gamma-irradiated corneas (Figure 4.1C), indicating less crosslinking 
density (p = 0.036).   
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4. 3. 2. Thermal properties 
The thermal properties, which represent matrix organization, differed between the 
gamma-irradiated and the fresh corneas. The denaturation temperature of whole gamma-
irradiated corneas (61.8 ± 1.1 ⁰C) was significantly lower than that of fresh corneas (66.1 
± 1.9 ⁰C, p = 0.004, Figure 4.2A and C). This difference varied based on region, with 
similar denaturation temperatures in central regions (p = 0.413), but significantly lower in 
the peripheral region of gamma-irradiated corneas (p = 0.029, Figure 4.2B). Within 
gamma-irradiated corneas, the denaturation temperature of the central region of (64.2 ± 
1.3 ⁰C) was significantly higher (p = 0.010) than the peripheral regions (61.3 ± 1.5 ⁰C). 
The denaturation temperatures of central (66.5 ± 3.0 ⁰C) and peripheral (64.7 ± 2.8 ⁰C) 
regions of fresh corneas were similar (p = 0.149, Figure 4.2B).   
4. 3. 3. Macro- and microstructures of corneas 
H&E staining and transmission electron microscopy (TEM) of the mid-peripheral 
region were used to measure the structure of gamma-irradiated corneas. Many 
keratocytes were found in the stromal layer of fresh corneas, whereas minimal cellular 
debris was observed in the stromal layer of gamma-irradiated corneas (Figure 4.3). In the 
TEM images, the gamma-irradiated cornea demonstrated lower collagen fibril density 
than did the fresh cornea (Figure 4.4A). Although intact cellular structures could not be 
detected, some cellular fragments were observed in the gamma-irradiated cornea stromal 
sample (Figure 4.4B). In a defined 1-µm
2 
area, the density of collagen fibrils in the 
gamma-irradiated cornea stromal sample (160.6 ± 33.2 fibrils/µm
2
) was significantly 
lower than that in the fresh cornea stromal sample (310.0 ± 44.7 fibrils/µm
2
, p = 0.001, 
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Figure 4.4C). Qualitatively, we observed thinner collagen fibrils in the gamma-irradiated 
corneas compared with fresh corneas.  Additionally, the density of collagen fibrils in 
gamma-irradiated cornea stromal samples ranged from 80 to 240 fibrils/µm
2
 whereas 
fibril density in the fresh cornea stromal samples ranged from 260 to 400 fibrils/µm
2
 
(Figure 4.4D).   
4. 3. 4. DNA content of the corneas and human corneal epithelial cell proliferation test 
Regarding biological properties, the residual cell content (amount of DNA) was 
decreased after gamma-irradiation, with gamma-irradiated corneas (1.04 ± 0.11 µg 
DNA/mg- dry tissue) containing significantly (p = 0.004) less DNA than fresh corneas 
(1.90 ± 0.22 µg/mg) as shown in the morphological evaluation (Figure 4.5A). However, 
seeded cells did not respond differently to the gamma-irradiated and fresh corneas. There 
were no significant differences between proliferation of hCECs on the fresh and gamma-
irradiated cornea at any time point over the course of 21 days (Figure 4.5B). In general, 
cell proliferation increased over the course of 14 days, and was more abundant when 
compared with TCP. Between 14 and 21 days, the proliferation of hCECs in both corneas 
decreased whereas proliferation did not change on TCP (Figure 4.5B). 
 
4. 4. Discussion 
Characterization of a biological material is important in establishing suitability for 
clinical application. Despite the availability of the gamma-irradiated donor human 
corneas to ophthalmic surgeons, many fundamental properties have not been carefully 
evaluated.  In this study, we characterized several physical and biological properties, 
53 
 
including swelling ratio, light transmittance, elastic modulus, denaturation temperature, 
collagen fibril density, DNA content, and corneal epithelial cell proliferation.   
Corneal ECM is an optically clear hydrogel compromised of primarily collagen 
and proteoglycans [46]. It is well known that the amount of crosslinking (crosslinking 
density) governs the physical properties of a hydrogel [120] and many riboflavin-UVA 
crosslinking studies demonstrated this with corneal tissue. When the crosslinking density 
of corneal ECM is increased, light transmittance, one of the main properties of the cornea, 
increases [121], as do the degree of material stiffness [122, 123] and brittleness [124], 
which limit surgical handling while decreasing the swelling ratio [121]. Thus, the 
crosslinking density, which affects the physical properties of corneal ECM, must be 
balanced to ensure optimal qualities for a corneal replacement tissue. We demonstrated 
that the gamma-irradiated cornea shared similar hydration, light transmittance, and elastic 
modulus as the fresh cornea, indicating that gamma-irradiated corneas have the ideal 
crosslinking density. In addition, these shared properties suggest that 17-23 kGy 
irradiation does not affect certain functional qualities of human cornea. Therefore, they 
could potentially share functional aspects of the fresh cornea, including surgical handling 
of the tissue and quality of vision. An example is lamellar keratoplasty where stromal and 
epithelial (but not endothelial) corneal tissue can be replaced by gamma-irradiated cornea.  
Nevertheless, the denaturation temperature and collagen fibril density were 
significantly lower in the gamma-irradiated corneas than in fresh corneas. Thermal 
analysis provides information about the hierarchical organization of tissue [109], 
including corneal tissue [125] and its substitutable biomaterial [88]. The difference in 
denaturation temperature in our study indicates that matrix organization of the cornea was 
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altered by 17-23 kGy gamma-irradiation. Although there is little information as to how 
thermal properties of ECM affects corneal function, the matrix alteration by this amount 
of irradiation may not be great enough to change the crosslinking density of the cornea. 
Thermal analysis also showed the denaturation temperature in the peripheral cornea is 
lower than that in the central cornea. This finding may be related to the fact that the 
structure of corneal ECM differs depending on location within the cornea. For example, 
the central cornea has a thinner stromal layer [126], a higher collagen density [127], a 
thinner collagen diameter [128], and a higher hydration [129] than the peripheral cornea. 
These regional differences in ECM may influence the regional effect of gamma 
irradiation.  Future studies could examine how irradiation may be performed to account 
for these localized differences.  
Collagen density of corneas varies depending on the region and depth of the 
cornea, tending to be higher in the central and posterior regions than in the peripheral and 
mid-cornea [127, 130]. Owing to this variation, we performed micro-structural 
assessments in a specific area of cornea: the mid-peripheral region at mid-stromal depth. 
In our study, the human mid-peripheral and mid-stromal cornea density (310.0 ± 44.7 
fibrils/µm
2
) was lower than what has been reported for the rabbit central and posterior-
stromal cornea (396 ± 21 fibrils/µm
2
) [118], although others reported the human cornea 
to have higher collagen fibril density than that of rabbit [130]. Furthermore, collagen 
fibril density of the irradiated cornea was significantly lower than that of the fresh cornea. 
However, a previous study reported collagen density was decreased in the superficial area 
but not significantly different in the other area of gamma-irradiated human 
corneas
17
Owing to the irradiation dose-dependent structural changes in the various 
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studies mentioned above, we suggest that the low fibril density of irradiated corneas is 
caused by the application of 17-23 kGy gamma irradiation, which may be different from 
other studies. 
We demonstrated that light transmittance of gamma-irradiated cornea was not 
significantly different from that of fresh cornea. However, a recent study indicated that 
transmission was improved in irradiated versus fresh corneas at certain wavelengths 
[117]. We believe that this discrepancy is due to differences in the sample size, the 
methods for transmittance measurement, and statistical analysis between present and 
previous studies. However, both studies clearly demonstrated similar light transmission 
properties of fresh and gamma-irradiated corneas. Corneal transparency increases with 
small-diameter collagen fibrils and low interfibrillar spacing [116]. Because the collagen 
fibril density of gamma-irradiated corneas was lower than that of fresh corneas in our 
study, but transparency was unchanged, we posit that the small diameter of collagen fibril 
in the gamma-irradiated cornea increases transparency, which compensates for decreased 
corneal transparency by increased interfibrillar spacing.  
Because the ECM strongly influences cell physiology, cell-based studies are 
essential to characterize the biological properties of the gamma-irradiated cornea [131]. 
Corneal epithelialization is the first step of corneal healing [132]. By measuring the rate 
of CEC proliferation, one can estimate the potential of a biomaterial for corneal 
reconstruction. In our study, the proliferation rate of hCECs was not significantly 
changed between fresh and irradiated corneas, indicating that the materials are equally 
compatible, although in vivo studies would be necessary to confirm. However, a previous 
study reported that the proliferation of rabbit CECs correlated with increased collagen 
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coating density on a synthetic material [131]. The discrepancy in proliferation between 
these two studies may be attributed to differences in supporting materials and cell sources. 
Our study was conducted using fresh and gamma-irradiated human corneas and human 
CECs, which we believe to be clinically relevant.  
Although hCEC proliferation was similar in fresh and irradiated corneas, gamma-
irradiation appeared to reduce the number of keratocytes in the stroma as well as DNA 
content. A previous mouse penetrating keratoplasty study similarly showed the potential 
of gamma irradiation to decrease the risk of immune rejection by damaging donor 
keratocytes [104]. DNA content of both donor tissue and contaminating pathogens are 
known to activate immune response [133],  and allogeneic DNA may contribute to 
immune rejection by activating the major histocompatibility-I (MHC-I) class molecule 
[134, 135]. Thus, by damaging both keratocytes and DNA, irradiating transplant material 
could reduce immune rejection. 
Fresh human cornea tissue prepared for tissue donation should be used within 14 
days when kept in a preserved solution between 2-8ºC in a refrigerator [136]. One of the 
advantages of gamma-irradiation is that the procedure extends shelf life up to 2 years 
without complex storage requirements. Nevertheless, outdated gamma-irradiated corneas 
had a lower swelling ratio (lower crosslinking density) than normal gamma-irradiated 
corneas, suggesting a finite shelf life for gamma-irradiated corneas as they undergo 
structural alterations with time. The decrease in light transmittance and elastic modulus 
over time support this theory. Strategies to maintain crosslinking density in the gamma-
irradiated cornea should be investigated to maximize the shelf life.  
57 
 
In conclusion, we have characterized the mechanical and biological properties of 
gamma-irradiated corneas and compare them with the properties of fresh human corneas. 
Gamma-irradiated corneas and fresh corneas have similar physical and biological 
properties, which imply the 17-23 kGy of gamma irradiation does not affect surgical 
handling, the healing process by epithelial cells, and the tissue clarity. However, it is 
notable that the density of fibrils and the thermal stability of gamma-irradiated cornea are 
less than those of fresh cornea. Because of the similar biological and mechanical 
properties between irradiated and fresh corneas, longer shelf-life of gamma-irradiated 
corneas compared to fresh donor tissue, and decreased risk of rejection, gamma-irradiated 





Figure 4. 1. Light transmission, compressive modulus, and hydration of fresh 
gamma-irradiated corneas, and outdated gamma-irradiated corneas. (A) 
Transmittance of visible wavelengths every 10 nm from 400 to 700 nm, (B) elastic 
modulus, and (C) swelling ratio [ratio of wet weight (ww) to dry weight (dw)] were 
determined for fresh (n = 5), gamma-irradiated (n = 5) and outdated gamma-irradiated (n 
= 3) corneas. * p < 0.05 versus outdated corneas unless otherwise noted,  Mann-Whitney 




Figure 4. 2. Thermal properties of fresh and gamma-irradiated corneas. 
Denaturation temperature across the whole area (A) and in the central and peripheral 
areas of corneas (B). Data in (A and B) are means ± SD (n = 5). (C) Representative DSC 
thermograms for fresh and gamma-irradiated corneas. Black arrows indicate denaturation 
curves in the thermogram. Statistical significance was established by one-tailed Student’s 




Figure 4. 3. Histology of fresh and gamma-irradiated corneas.  H&E staining of the 
mid-peripheral region revealed structure, keratocytes, and debris in gamma-irradiated 
corneas. Keratocytes are seen in blue in the fresh cornea. Cell-like debris (red arrow) was 




Figure 4. 4. Transmission electron micrographs of fresh and gamma-irradiated 
human corneas in the mid-peripheral region. (A) TEM images of fresh and gamma-
irradiated corneas, (B) Cell fragments (indicated by white arrows) in gamma-irradiated 
corneas. (C and D) Collagen fibrils and fibril density quantified in 50 randomly chosen 1-
µm
2




Figure 4. 5. Biological characterization of fresh and gamma-irradiated corneas. (A) 
DNA content in fresh and gamma-irradiated corneas relative to dry weight. (B) 
Proliferation rate of hCECs over 21 days after seeding on fresh and gamma-irradiated 
corneas and on tissue culture plate (TCP). * P<0.05 compared to TCP unless otherwise 








5. 1. Introduction 
Corneal blindness, resulting from corneal diseases or injuries, is the fourth leading 
cause of blindness worldwide [24]. Although allogenic corneal transplantation is the only 
effective method for restoring vision from corneal blindness and its success rate is 
relatively high, global donor shortages limit the application of this excellent treatment [30, 
137]. To address this issue, many researchers have attempted to develop corneal 
substitutes, widely categorized within two types: synthetic keratoprostheses and tissue-
engineered corneal substitutes [60]. Among tissue-engineered corneal equivalents, both 
bottom-up and top-down approaches have been used.  
Several keratoprostheses, such as AlphaCore
TM
, have been used clinically [138].  
However, they could still be inappropriate for long-term use due to their severe 
complications including poor integration with host tissue, progressive stromal melting, 
epithelial defects, glaucoma and endophthalmitis [139, 140]. The bottom-up approach 
also has produced various corneal equivalents from components of corneal extracellular 
matrix (ECM), such as collagen [132, 141] and glycosaminoglycans (GAGs) [142] as 
well as other proteins such as silk fibrin [143]. Despite their potential, all engineered 
corneas to date have been unable to attain the ideal characteristics of successful corneal 
application including transparency, proper curvature, non-toxicity, non-immunogenicity, 
and proper mechanical and biological properties. For example, the recombinant human 
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collagen-based implant may be limited by its poor mechanical properties and inability to 
withstand conventional suture techniques in clinical trials [47]. Top-down approaches 
including tissue-based corneal substitutes have recently remerged as an alternative 
strategy. The gamma-irradiated human cornea has shown great characteristics in a 
previous study and is clinically available [64]. However, the irradiated human may 
alleviate the donor shortage issue but not completely address it.   
Decellularization of xeno-originated corneas is an attractive top-down approach. 
The animal cornea is relatively inexpensive, easily obtained and has similar protein 
compositions when compared to the human cornea [62]. In addition, decellularized xeno-
originated tissue generally contains most  native tissue composition including  various 
functional proteins such as integrins that improve biological properties [144]. To ensure 
successful corneal xenotransplantation, the efficient removal of the main animal antigen, 
cell components, is required [145]. Although decellularization methods have been applied 
to animal corneas in many studies, their effects have not clearly quantified and a 
standardized protocol has not been developed [58]. Another significant problem of this 
approach is that most decellularization processes causes structural damage to the corneal 
ECM [60, 146, 147]. Damaged corneal ECM loses its unique transparency and curvature 
and as a result, two of its critical functions: allowing light penetration and generating 
refractive power, are also lost. A gentle decellularization method is available to maintain 
the corneal structure to some extent. However, the method leaves cell components in 
corneal ECM which would induce immune rejection after transplantation [57, 62]. For 




Recently, our group has developed technologies to manipulate structures of 
collagen ECM with the ultimate goal of producing optimal corneal substitutes. 
Vitrification is a process to control the fibril structure of collagen biomaterials [50, 88]. 
By controlled evaporation of water under the specific temperature and humidity, the 
vitrification process allows self-organization of collagen fibrils which has an impact on 
the optical, mechanical, and thermal properties of the collagen biomaterial as well as 
keratocyte behavior [50, 88]. Another significant method is the process of customizing 
the three dimensional shape of the collagen material using a single mold. We previously 
reported that the shaped collagen material (collagen vitrigel: CV) was successfully 
constructed and that the material improved the applicability for implanting to cadaveric 
eyes [72]. Due to sharing the main composition of native cornea [8], type I collagen, 
these technologies may be able to manipulate the ECM structure of the cornea similarly 
to CV. In addition, these methods have the potential to reconstruct the damage 
decellularized cornea after decellularization processes.  
The present study was performed to produce an optimal xenotransplantable 
corneal substitute based on the decellularization approach used with structural 
reconstruction methods. To achieve this goal, we investigated various decellularization 
methods to develop a protocol for the porcine cornea first. After, the decellularized 
cornea produced from the optimized protocol was reconstructed with our novel 
technologies with modified methods. In addition, corneas were characterized to evaluate 
the properties of corneal ECM as well as the validity of these technologies. Finally, the 
optimized corneal substitute was applied to two animal models to assess biocompatibility 




5. 2.  Materials and Methods 
5. 2. 1.  Animals 
Eight New Zealand white rabbits, 2 to 3.5 kg in weight, were used for two animal 
models according to the Association for Research in Vision and Ophthalmology (ARVO) 
Statement for the Use of Animals in Ophthalmic and Visual Research. In addition, all 
experimental procedures were approved by the Institutional Animal Care and Use 
Committee at Johns Hopkins University. 
5. 2. 2. Preparation of porcine corneas with conventional decellularization methods 
Whole porcine eyes were obtained from a local butchery within 24 hours post-
mortem. The full thickness cornea buttons were prepared using a 12 mm-diameter biopsy 
punch and then washed in a sterile balanced buffer solution (BBS) with 5% antibiotic / 
antimycotic solution (Anti-anti, Gibco, 15240)  three times.  The corneas were then 
divided into eight groups: 1) The native cornea as a control group; three physically 
treated groups including 2) freezing-thawing, 3) hyperosmolar dextran and 4) hypertonic 
sodium chloride (NaCl) groups; two chemically treated groups including 5) sodium 
dodecyl sulfate (SDS) and 6) Triton-X groups; and two enzymatically treated groups 
including 7) fetal bovine serum (FBS) and 8) DNase treated groups. Corneas were treated 
with one of the following methods: 1) Fresh cornea without any treatment 2) corneas 
treated five times with liquid nitrogen freezing for 30 minutes, and thawing at room 
temperature for 3 hours. 3) Corneas immersed in  20% (w/w) of hyperosmolar dextran 
(Fisher 1004-00-60 ) solution at 4°C for 3 days, 4) corneas in the 2.0 mol hypertonic 
NaCl (Fisher 7647-14-5 )  solution at 37°C for 3 days, 5) corneas in the 1% (v/v) SDS 
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(Sigma 71727) solution at room temperature for 3 days  6) corneas in the 1% (v/v) 
Triton-X (Sigma 9234) solution at room temperature for 3 days 7) corneas in the 10% 
FBS (Thermo Fisher Scientific, USA) with Dulbecco's Modified Eagle Medium (DMEM, 
Gibco 31053) at 37°C for 3 days and 8) corneas in the 600U/ml DNase I (Roche, 
Germany) solution with PBS at 37°C for 3 days. Corneas in group 3) to group 6) were 
treated on a conventional magnetic stirrer at 150rpm and those in group 7) and 8) were 
done on a gyrator rocker at 70rpm. After treatment, each cornea was irrigated using 
sterile PBS three times. 
5. 2. 3.  Decellularization process   
Selected decellularization methods were combined to maximize cell removal. 
After washing corneal buttons with 5% antibiotic solution as described before, the fresh 
porcine corneas were treated with 1% SDS followed by 1% Triton-X for 3 days at room 
temperature respectively . The corneas were aseptically washed in sterile PBS on a 
conventional magnetic stirrer at 180 rpm for 7 days at room temperature to remove 
remnant chemical agents. Next, the corneas were placed in 10% fetal bovine serum in 
DMEM for 3 days at 37⁰C and were then washed with PBS containing 1% 
antibiotic/antimycotic for 24 hours. The cornea treated by those 3 decellularization 
methods will be called the decellularized cornea (DC) in this study. Each 
decellularization process was agitated as described above.  
5. 2. 4.  Microscopic structural reconstruction 
To reconstruct the microstructure of DC, two processes, vitrification and 
riboflavin crosslinking (the reconstruction process), were conducted. The vitrification 
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process was performed with a modified method from a previous study [148].  After 
tearing the Descemet’s membrane, DC was placed in a conventional tissue culture plate 
(TCP) and incubated at 4°C in 40% relative humidity for 3 days followed with a 1 hour 
PBS wash. Afterwards, the cornea was vitrified by drying at 37°C for a week in 
40%relative humidity within a vitrification chamber.  Riboflavin crosslinking was used to 
increase material stability.  After rinsing with PBS, the vitrified DC was immersed in a 
20% dextrose solution with 0.1% Riboflavin (Sigma, R7649) overnight at 4°C. The 
cornea was washed with 20% dextrose solution and was cross-linked using UV radiation 
(370nm, 3.0mW/cm
2
) for 1.5 hours on both sides.  The DC with the applied 
reconstruction process will be called the reconstructed cornea (RC) in this study.  If it is 
not specified, RC was made on a flat TCP.  
5. 2. 5.  Histology  
Corneas (n=5) were dehydrated and imbedded in paraffin. Sections (5 µm thick) 
were stained with either hematoxylin and eosin (H&E) or Alcian blue, using standard 
techniques. The stained slides were observed under a light microscopy (Observer A2, 
Carl Zeiss, Germany). 
5. 2. 6.  Light transmittance assay 
After each process, five corneas were cut with a 10-mm trephine for each group 
and washed 3 times using BSS. With a multimode microplate reader (Synergy 2, Biotek, 
Seattle, WA), the light transmittance of the corneas on a 48-well microplate was 
measured in the full visible spectrum. Using obtained absorbance data, the light 
transmittance was calculated by the Beer-Lambert law with the equation, transmittance 
(%) = e
-absorbance
 x 100 as a previous study [64]. 
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5. 2. 7.  Biochemical analysis – DNA contents, GAG and Collagen 
Corneas (n=5) were lyophilized for 48 hours and the dry masses were taken.  The 
lyophilized cornea was digested in a 125-µg/mL papain solution (Worthington, 
Lakewood, NJ) for 16 hours at 60 °C. Quantification of DNA content was performed 
using a Hoescht Dye 33342 DNA assay as a previous study [64]. The fluorescent 
intensity of the mixture composed of the papain digestion and Hoechst dye in TNE buffer 
was measure using a fluorometer (DyNA Quant 200, Hoefer, Holliston, MA). The DNA 
content was calculated using the standard curve generated by calf thymus DNA.  The 
amount of sulfated GAG (sGAG) were measured using a 1,9-dimethylmethylene blue 
(DMMB) dye assay [149].  Papain-digested samples were mixed with a DMMB dye 
solution and the mixture was quantified using a spectrophotometer at 525nm. The 
quantified data were calculated by the standard curve made from chondroitin sulfate 
standards. Collagen was quantified with a hydroxyproline content assay [149]. The 
papain digestion was incubated in 6 N hydrogen chloride overnight at 125°C, neutralized 
and oxidized with chloramine-T. After, p-dimethylaminobenzaldehyde was added to the 
solution and its absorbance at a wavelength of 550 nm was measured. Hydroxyproline 
was used for generating a standard curve.  
5. 2. 8.  Western Blot 
To evaluate the amount of remnant cell debris, fresh porcine, SDS and Triton-X 
treated and decellularized corneas (n=5) were homogenized using a pestle and a mortar in 
liquid nitrogen. Confluent porcine keratocyte-induced fibroblasts were harvested (n=5 
well) in a 6-well plate to serve as a control group. After washing samples twice using ice-
cold PBS, each sample was lysed with RIPA buffer (ThermoFisher Scientific) containing 
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protease inhibitor mixture (Sigma) according to the manufacturer’s instructions. Protein 
concentration was quantified using the BCA assay kit (Pierce).  Using 10% SDS-PAGE, 
proteins were separated and transferred onto a polyvinylidene difluoride (PVDF) 
membrane.  The membrane was blocked for 2 hours using 5% non-fat dry milk in Tris-
buffered saline containing 0.1% tween-20 (TBS-T).  Primary β-actin (1:300, Sigma, USA) 
antibody was applied overnight at 4°C, followed by horseradish peroxidase conjugated 
secondary antibodies (1:5000, Bio-Rad) for 1 hour at room temperature. Finally, β-actin 
was detected by chemiluminescence (Thermo Scientific).   
5. 2. 9.  Transmission electron microscopy and Quantities collagen fibers 
Corneas (n=5) were fixed using a mixture of 3%  paraformaldehyde, 1.5% 
glutaraldehyde, 5 mM MgCl2, 5 mM CaCl2, 2.5% sucrose, and 0.1% tannic acid in 0.1 
M sodium cacodylate buffer at pH 7.2 overnight in a cold room. The samples were rinsed 
in PBS buffer and post-fixed with 1% osmium tetroxide on ice for 1 hour. After a 
deionized water rinse, the sample was en bloc stained in Kellenberger uranyl acetate 
overnight.  Following dehydration with a graded series (75%, 95%, and 100%) of chilled 
ethanol solutions, the sample was infiltrated with Eponate 12 resin (Ted Pella, Redding, 
CA) at 60⁰C for 60 to 96 hours.  The resin embedded samples were cut using an ultra-
microtome (Ultracut UCT, Leica, Wien, Austria), collected on grids, and stained with 
uranyl acetate. The samples were examined and electronic digital pictures were taken 
using a TEM (Philips 420, FEI Co., Hillsboro, OR) system at 80 kV. After images were 
taken, ten TEM images in each cornea were magnified approximately 100,000-fold. Five 
areas were randomly chosen in each picture, and areas were defined as 1  1 µm
2
. The 
collagen fibers were manually counted by two masked observers. A collagen fiber in the 
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center of each picture was selected and its diameter was measured using computer 
software (Axiovision, Zeiss, Germany). 
5. 2. 10. Thickness and Hydration 
The thickness of five corneas was measured using a Starrett thickness gage after 
each process. To estimate crosslinking density, hydration was measured. After removing 
excess corneal fluids corneas (n=5) with a filter paper, wet weight (Ww) of each cornea 
was measured with a standard scale and the corneas were lyophilized for 48 hours to 
calculate dry weight (Wd).  Hydration (H) was calculated using the following equation: H 
= Ww / Wd as a previous study [64] 
5. 2. 11.  Compressive modulus 
Compressive modulus was measured to evaluate stiffness of corneas after each 
procedure as a previous study [64]. Briefly, compression was applied to the corneas (n=5) 
from 0% to 10% thickness using an Electroforce 3200 testing instrument (Bose, Eden 
Prairie, MN) with a 250-g load cell. To calculate compressive modulus, a computer 
program (MATLAB, MathWorks, Natick, MA) was used. 
5. 2. 12.  Thermal properties 
Thermal properties of each cornea (n=5) were characterized using differential 
scanning calorimetry [DSC (DSC 8000, PerkinElmer, Norwalk, CT)] as described 
previously [64]. Samples were collected in the central cornea using a 5-mm biopsy punch. 
The collected samples were weighted and sealed in a 30-μL aluminum pan. An empty 
sealed pan was served as a reference. The specimens were cooled from room temperature 
to -30°C under nitrogen flow, and then heated to 90°C at a rate of 5°C/min. The produced 
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thermograms were evaluated and the denaturation temperature was automatically 
calculated using the Pyris series software (PerkinElmer, Norwalk, CT).  
5. 2. 13.  Collagenase degradation test 
To evaluate the collagenase resistance of each cornea, collagenase degradation 
tests were performed. After rinsing 3 times with PBS and removing excess water content 
with a filter paper, corneas (n=5) in each group were immersed in 5 mg/mL type I 
collagenase (Worthington Biochemical Corp., Lakewood, NJ ) with DMEM. At every 
hour, the corneas were weighted after gently removing the water contents on the surface. 
The ratio of initial mass to the mass at each time point was calculated to present the 
percentage of residual corneal mass.  
5. 2. 14.  Macroscopic structural reconstruction 
To generate curvature of RC, macrostructural reconstruction was performed 
(Figure 5.1).  Pairs of Polymethyl methacrylate (PMMA) molds (Figure 5.1A) following 
curvature of the rabbit cornea (7.5mm) were kindly donated from eyegenix LLC 
(Honolulu, HI). After removing the posterior layer, DC was placed on a curved mold 
(Figure 5.1B) and gentle pressure was applied to conjunct the bottom of DC to the 
surface of the mold (Figure 5.1C). After conducting the vitrification process (Figure 5.1D) 
as mentioned above, 100µl of 0.1% riboflavin with 20% dextran solution was applied 
(Figure 5.1E). Using conventional sealing paper, a pair of molds was combined each 
other and tightly sealed. The mold including DC was kept overnight at 4°C. After UV 
radiation, as mentioned above, was applied within the mold for 2 hours on both sides 
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(Figure 5.1F). After opening the mold (Figure 5.1G) and applying a few drops of PBS, 
the shape reconstructed cornea was carefully detached from the mold (Figure 5.1H). 
5. 2. 15.  Optical coherence tomography and curvature analysis 
The optical setup of the Optical coherence tomography (OCT) imaging system is 
shown in Figure 5.2A The home-built OCT imaging system consists of a swept source 
OEM engine (AXSUN, central wavelength λ0: 1060nm, sweeping rate: 100kHz, scan 
range: 3.7mm in air), a balanced photo-detector and a digitizer with a sampling rate of up 
to 500MSPS with 12-bit resolution, a Camera Link DAQ Board, and a Camera Link 
frame grabber (PCIe-1433, National Instruments). For the optical scanning head, 2D 
galvanometer mirrors (GVS002, Thorlabs) and OCT scan lens with 36mm effective focal 
length (LSM03-BB, Thorlabs) were used. The workstation (Precision T7500, Dell) with 
general-purpose computing on graphics processing units (GPGPU, GeForce GTX980, 
Nvidia) processed the sampled spectral data and reconstructed the 3D OCT image. The 
parallel processing (CUDA, Nvidia) of the GPGPU significantly reduced the signal 
processing time including FFT (Fast Fourier Transform). Finally, 512 x 512 x 1024 
volumetric OCT images were reconstructed and 10 duplicated 3D images were averaged 
to increase SNR (Signal-to-Noise Ratio). Based on the reinforced 3D OCT images, canny 
edge detection algorithm was applied in order to extract the curvature information of the 
shaped reconstructed cornea as well as the mold. Then, the gray-scale image was 
converted into a binary image with a specific threshold value to extract the surface line of 
the cornea and the mold. The surface binary image was rescaled in accordance with the 
physical scanning size. Using this final image, the mean value of curvature was 
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calculated by measuring 6 (3 by 3) different positions of the cornea as shown in Figure 
5.2B. 
5. 2. 16. Cell Culture (Human epithelial cell, Human keratocyte and Bovine 
endothelial cell)  
The human corneal epithelial cell, human keratocyte and bovine corneal 
endothelial cell were cultured to evaluate the cell response to DC and RC. Six human 
corneas were donated by Tissue Banks International (Baltimore, MD) and the study was 
approved by Johns Hopkins Institutional Review Boards. All human samples were 
handled following the Declaration of Helsinki. To culture the human corneal epithelial 
cells and keratocytes, the epithelium was separated from the stroma by treating with 1.2 
U/ml of dispase II (Roche Diagnostics, Mannheim, Germany) in the Epilife® medium 
(Invitrogen / Life Technologies, Grand Island, NY) at 4°C for 16 hours. Under a 
conventional dissection microscope, epithelial sheets were aseptically collected and 
transferred into a conical tube containing 0.05% trypsin-EDTA solution. The epithelial 
sheet was incubated at 37°C for 30 minutes and then human corneal epithelial cells were 
collected using a cell strainer. After mechanical disruption with a pipette and 
neutralization of trypsin-EDTA solution, primary cells were sub-cultured in the Epilife® 
medium with the Human cornea growth supplement (HCGS, Invitrogen/Life 




 until confluent.  
Human keratocytes were isolated using type I collagenase digestion. After 
collecting the epithelial sheet, the endothelium was removed and the remained stroma 
was cut into small pieces with a # 10 blade. The corneal pieces were incubated in 3 
mg/mL collagenase in DMEM/F-12 for 1 hour. The remaining corneal pieces were 
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collected and transferred to a fresh collagenase solution for 4 hours.  After repeating the 
process for a third 4 hour digestion, primary keratocytes were collected from the second 
and third digestion solutions using a cell strainer.  After obtaining cell pellets with a 
conventional method, keratocytes were subcultured in a DMEM solution containing 1% 
RPMI vitamin mix (Sigma), 100 μm non-essential amino acids (Gibco), 100 
μg/ml ascorbic acid (Sigma) and 1% antibiotic / antimycotic solution (Gibco) at 37°C and 
5% CO2 with a density of 5  104 cells/cm
2
 for a week.    
Bovine endothelial cells were harvested from six bovine eyes within 24 hours 
after slaughter.  The corneas were placed on a Petri dish with the endothelial side facing 
up. Under a dissection microscope, Descemet membranes with intact endothelium were 
peeled and incubated in 0.02% Tripson-EDTA for 1 hour at 37°C. After vigorous 
pipetting, bovine corneal endothelial cells were collected after passing through a cell 
strainer. The cells were seeded in a 6-well TCP te precoated using FNC Coating Mix 
(AthenaES , Baltimore, MD) with DMEM media including 10% FBS (Thermo Fisher 
Scientific), 50 ㎍/ml pituitary extract  (Sigma) and 1% antibiotic / antimycotic solution 




 until confluent.  
5. 2. 17.  Live/Dead cell analysis, immunocytochemistry and proliferation test 
To evaluate the cell behavior within corneas, 48-well plates were covered with the 
fresh porcine corneas:  either the decellularized or reconstructed cornea. Some of them 
were left untreated to serve as a control group. For the bovine endothelial cell study, pre-
coated TCPs with FNC Coating Mix were used as the control group. After subculturing 
as described above, corneal cells were detached using 0.05% trypsin-EDTA and seeded 
on either cornea covered or control TCPs. 
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In order to evaluate the cytotoxicity of the cornea, keratocytes were seeded on 




 for a week. The keratocytes 
were differentiated from fibroblasts with serum-based medium contained DMEM/F-12, 
10% FBS 1% antibiotic / antimycotic solution (Gibco) at 37°C and 5% CO2. The live 
and dead cells were observed with a kit (LIVE/DEAD® Viability/Cytotoxicity Kit, Life 
Technologies) according to the manual.  
For Immunocytochemical staining, corneal cells were seeded onto the corneas or 
TCP (n=4) as above. If it is not specified, the procedures were performed at room 
temperature. At 7 days after seeding cells, the cells were rinsed twice with PBS and fixed 
with 4% paraformaldehyde in PBS for 15 minutes. After washing twice with PBS, cells 
were permeabilized with 0.25% Triton® X-100 (Sigma, St. Louis, MO) for 10 minutes 
and then washed three times in PBS for 5 minutes. Using 5% Bovine serum albumin 
(BSA, Sigma), non-specific antibodies were blocked for 30 minutes. Primary antibodies 
were applied for overnight at 4°C and then incubated with respective secondary 
antibodies for 1 hour in the dark room as shown in Table 5.1. Using the Hoechst 33342 
solution (1µg/ml), all nuclei in the cells were stained for 1 minute and then, PBS 
washings were carried out twice. The cells were observed and photographed under a 
microscope system (Observer A2, Carl Zeiss, Germany). 
Proliferation tests were performed using the cell counting kit-8 (CCK-8, Dojindo 
Molecular Technology, Inc., Rockville, MD) following manufacturer instruction. The 
absorbance, corresponding to the number of cells, was measured with a multimode 
microplate reader (Synergy 2, Biotek, Seattle, WA) at 450 nm.  After seeding the three 




 density on corneas and TCP, the measurements 
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were performed until the corneal cells were confluent in the TCP. The endothelial cells, 
which rapidly proliferate, were measured every day whereas other cells were done at 0, 1 
and every other day after seeding cells. Due to quiescence, the test was not performed for 
the keratocyte.  
5. 2. 18.  Surgical procedures for interlamellar and anterior lamellar keratoplasty  
The procedures were performed under general anesthesia by intramuscular 
administration of ketamine (35 mg/kg of body weight) and xylazine (5 mg/kg of body 
weight).  After inducing general anesthesia, two drops of topical anesthesia (Proparacaine, 
Akorn, Lake Forest, IL ) were administered just prior to performing the surgical 
procedure. Two procedures were performed in this study: interlamellar keratoplasty and 
anterior lamellar keratoplasty.  
To evaluate the biocompatibility of RC, interlamellar keratoplasty was performed 
using four rabbits. An incision was created using 8 mm Hessburg-Barron vacuum 
trephine to about a half thickness depth of the full cornea. With a crescent knife, lamellar 
dissection was performed to produce an intrastromal pocket (Figure 5.3A). A flat RC, 
with a 6mm diameter and approximately 100 µm thickness, was inserted into the 
intrastromal pocket (Figure 5.3B and 5.3C). The incision was closed with two interrupt 
10-0 nylon sutures.  A gentamycin and prednisolone combined ophthalmic ointment 
(Pred-G, Allergan, Irvine, CA) was applied once a day for 3 days. General ophthalmic 
examinations was performed at 3, 7, 14 days and 1, 2, 3, 6 months after surgery. At 1 and 
6 months post-surgery, two rabbits were sacrificed respectively for further pathological 
examination with H&E stating.  
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To evaluate the clinical potency of RC as a corneal substitute, a pilot study was 
carried out using the anterior lamellar keratectomy model with 4 rabbits. Rabbits were 
randomly divided two groups: 3 rabbits for the RC group and 1 animal for the untreated 
negative control. Using 6mm Hessburg-Barron vacuum trephine (Barron Precision 
Instruments LLC, Grand Blanc, MI) and a crescent knife (LaserEdge, Bausch&Lomb, 
Rochester, NY), approximately 125 µm of anterior corneal tissue was removed from a 
randomly chosen eye of each rabbit. After inducing injuries, rabbits in RC cornea group 
received a shaped RC (approximately 125 µm thickness, 6.25mm diameter and 7.5mm 
curvature) affixed using 12-14 interrupted 10-0 nylon sutures. The negative control 
groupwas similarly operated on, but did not receive any material and rather, was allowed 
to heal naturally. A mixture of steroid and antibiotic ointment (Pred-G, Allergan, Irvine, 
CA) was applied for 14 days as a post-operative treatment. Gross observations, including 
ophthalmomicroscopy and fluorescein staining were performed at day 3, 7, 14 and 1 
month after surgery. In addition, In vivo pachymetry were carried out to calculate the 
thickness of the animal cornea before sacrificing using a pachymeter (Corneo-Gage 
plus
TM
, Sonogage, Cleveland, OH). Corneas were harvested after 30 days post-surgery 
for pathological examinations.  
5. 2. 19.  Statistical analysis 
Data are presented as means ± standard deviation (S.D.) and were analyzed by 
either the Mann-Whitney test or ANOVA test with the Bonferroni Post-hoc depending on 
the size and character of samples. Statistical analyses were carried out with SPSS 15.0 for 




5. 3. Results 
5. 3. 1.  Evaluation of decellularization methods 
To establish a valid decellularization protocol for the porcine cornea, 
conventional decellularizing methods were carried out and their effects were evaluated. 
Chemical and enzymatic treatments presented efficient methods to reduce cellular 
constituents. Histological examination revealed only cell debris remained in chemically 
and enzymatically treated porcine corneas (Figure 5.4A). In addition, the DNA content 
analysis supported this finding; the DNA contents were significantly decreased (p = 
0.004) after applying chemical and enzymatic decellularizing processes (Figure 5.4B). 
However, the mechanical methods left many visible keratocytes as well as their debris 
(Figure 5.4A), and could not significantly reduce DNA contents in the porcine cornea 
(Figure 5.4B). On gross observation, all decellularization methods reduced clarity of 
porcine corneas (Figure 5.5A). The finding on gross observation was confirmed by the 
quantitative light transmittance test: light transmittance at a representative visible wave 
length (550 nm) of all treated corneas was significantly (p = 0.008) decreased after a 
single decellularization process (Figure 5.5B).  
5. 3. 2.  Characterization of the decellularized cornea with an optimized decellularization 
protocol  
Although chemical and enzymatic decellularization methods presented their 
efficiency, the degree cellular component removal of a single method was limited. To 
maximize the decellularizing efficiency, a decellularization protocol, including 
applications of two chemical methods (SDS, Triton-X treatment) and one enzymatic 
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method (FBS), was performed to porcine corneas. The decellularization efficiency was 
demonstrated with the DNA assay. The assay revealed that the DNA content of the 
porcine corneas was significantly reduced (p=0.008, all treatment) following each 
treatment. In addition, approximately 97% of porcine DNA (3.30 ± 0.10 µg /mg to 0.14 ± 
0.03 µg /mg) was removed in the cornea after the protocol (Figure 5.6A). To analyze the 
removal of cell contents, the western bolt using a cell content marker, β-actin, was 
performed. The produced decellularized cornea (DC) was depleted of β-actin implying 
the cell contents were removed after the protocol (Figure 5.6B). However, the light 
transmittance test presented transparency of the porcine cornea was significantly 
decreased (p = 0.08) after chemical treatments in representing visible wave lengths (450, 
550 and 650 nm, Figure 5.6C).  In addition, quantitative collagen and GAG assays 
revealed ECM collagen and GAG were significantly decreased (p = 0.032 in collagen and 
p = 0.008 in GAGs contents) after the decellularization protocol (92.5% of collagen; and 
41.5% of GAG remains in the decellularized cornea, Figure 5.7). 
5. 3. 3.  Characterization of the decellularized and the reconstructed cornea 
To improve the physical properties of DC, vitrification and riboflavin crosslinking 
(reconstruction process) were conducted. On gross observation, clarity of DC was 
increased after the reconstruction process. However, yellowish color from riboflavin was 
observed in the RC (Figure 5.8A). The light transmittance test was confirmed those 
finding. Light transmittance was significantly increased (p = 0.08) after the 
reconstruction process in all visible wave length (400 nm to 700 nm). However, 
transparency of the reconstructed cornea was significantly lower (p = 0.08) than that of 
the native cornea. In addition, between 430 nm to 480 nm of wave length, the graph of 
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light transmittance was bulged indicating the cornea was stained with yellow color with 
riboflavin (Figure 5.8B).  
Histological assessment for evaluation of the macrostructure with H&E and 
Alcian blue staining revealed neither visible cells nor cellular elements were found in DC 
as well as RC (Figure 5.9). The collagen structure of DC was severely distorted as shown 
by its opacity during gross observation and the light transmittance test. The distorted 
collagen structure of DC was reconstructed to a compact structure after the reconstruction 
process (Figure 5.9).  In the Alcian blue staining, DC was palely stained by blue color 
indicating depletion of GAG contents. However, the intensity of staining was increased 
after the reconstruction process in RC (Figure 5.9).   
The ultrastructural evaluation with TEM presented severe structural alteration in 
DC which was reorganized in the reconstructed cornea (Figure 5.10). Although the 
orientation of corneal ECM was disassembled, no cell remnants were visible in the DC. 
As shown in the macrostructural assessment, the reconstruction process demonstrated its 
role by rebuilding unorganized collagen structure. The cornea reconstruction processing 
produced a layer-by-layer structure, similar with that of the fresh porcine cornea (Figure 
5.10A). Quantitative analysis of TEM images presented decreased collagen fibril density 
after the decellularization procedure, compatible with translucent appearance of the 
decellularized cornea. However, the density was significantly increased (p = 0.08) after 
the reconstruction procedure and light transmittance of the reconstructed cornea was 
improved (Figure 5.10B). However, the diameter of collagen fibrils showed a different 
trend. The diameter did not increase after the reconstructed procedure, but gradually 
decreased during the processing (Figure 5.10C).  
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The decellularization process also altered many properties including thickness, 
hydration and denaturation temperature. The decellularization procedure significantly 
increased thickness of the corneas (1.03 ± 0.14 mm to 8.88 ± 1.21 mm, p = 0.008, Figure 
5.11A) and hydration (10.04 ± 0.84 to 25.83 ± 3.24, p = 0.008, Figure 5.11B), and 
decreased the denaturation temperature (65.85 ± 0.52 °C to 53.58 ± 2.06 °C, p = 0.008, 
Figure 5.12). After reconstruction, the properties were repaired but some were not fully 
restored. Thickness of RC (0.85 ± 0.06) was significantly (p = 0.032) decreased when 
compared to that of the native porcine cornea (Figure 5.11A). In addition, the hydration 
of the reconstructed cornea (8.1 ± 0.95) also followed the result of the corneal thickness 
(p = 0.008, Figure 5.11B). However, the denature temperature of the reconstructed cornea 
(65.26 ± 1.37 °C) was not significantly different (p = 0.421) from that of the native 
porcine cornea and the reduced height of the peak was also restored after the 
reconstruction process (Figure 5.12).  
On the other hand, the compressive modulus of corneas showed a different trend. 
There was no significant difference of elasticity between fresh (16.90 ± 5.30 kPa) and 
decellularized corneas (12.63 ± 4.09 kPa, p = 0.310). However, the reconstruction 
process significantly increased stiffness of RC (33.80 ± 6.93 kPa,  p = 0.008, Figure 
5.13A). 
To evaluate the collagenase resistance of corneas, the collagenase degradation test 
was performed. The decellularization process decreased whereas reconstruction increased 
the collagenase resistance of corneas. To be fully degraded in in 5 mg/mL type I 
collagenase, the native and the decellularized cornea took 7 and 6 hours respectively. 
During 6 hours period, the percentage of the remaining DC was significantly lower (p = 
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0.008) than that of the remaining native cornea in each time point. The reconstruction 
process extended the full degradation time up to 9 hours. Except 5 hours after starting the 
test, the percentage of residual RC is significantly higher than that of the residual native 
cornea for 8 hours (Figure 5.13B). 
5. 3. 4.  Cell behavior test 
The live/dead cell analysis was performed to check the cytotoxicity of corneas 
using keratocyte-induced fibroblasts. None of the corneas showed cytotoxicity.  Only a 
few numbers of dead cells with red color were found, but the majority of cells were 
stained green implying that they lived well on corneas and TCP (Figure 5.14).   
The cell proliferation test was performed to evaluate the ability of corneal cells to 
repopulate the corneas. All corneas and TCP allowed for the rapid proliferation of 
keratocyte-induced fibroblasts. There were no significant differences of proliferate rates 
among the groups and time points (Figure 5.15A). Corneal epithelial and endothelial cells 
shared a similar proliferation pattern on corneas and TCP. Although the cells on TCP 
present the highest proliferation rates, RC allowed more rapid growth for both types of 
cells than DC and the native cornea. However, the native cornea barely allowed 
proliferation of both cell types until cells were confluent on TCP (Figure 5.15B and C).  
The capacity of the corneas to support corneal cells was evaluated with 
immunocyotochemistry with cell specific markers. The human corneal epithelial cells 
with cytokeratine 3 (K3) antibody staining revealed the cells on DC and RC formed many 
clusters expressing the K3 protein similarly to those on TCP. However, the size of cells 
on DC and RC was smaller than those on TCP. The cells on the native cornea could not 
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make a cluster form but only a few cells were scattered on the cornea. The human 
keratocyte was well distributed on all corneas and TCP and all cells presented a strong a 
keratocyte-specific protein, keratocan,-positive regions. Seeded bovine corneal 
endothelial cells mostly covered RC and DC as well as TCP. In addition, the cells 
showed expression of a tight-junction associate protein (ZO-1) on both the RC and DC as 
on TCP.  However, the bovine endothelial cells on the native cornea covered only limited 
area and barely expressed the ZO-1 protein (Figure 5.16). 
5. 3. 5.  Evaluation of Macroscopic structural reconstruction  
Using an OCT system, the regenerated concave shape of RC regarding curvature 
of the rabbit cornea was evaluated. The 3D OCT image revealed the shaped RC had a 
similar architecture with the mold. In addition, RC presented a smooth surface in 2D 
OCT image (Figure 5.17). In the curvature analysis, the curvature of the reconstructed 
cornea (7.613 ± 0.136 mm) was identical with that of the mold (7.615 ± 0.138 mm). 
5. 3. 6. Interlamellar corneal transplantation 
To evaluate the biocompatibility of RC, a pilot interlamellar keratoplasty was 
performed with a rabbit model.  The rabbit cornea kept the transparency and any 
significant lesions, including immune rejection, were not found during the 6 month 
period. In addition, the yellowish color of the reconstructed cornea was gone within a 
month after implantation (Figure 5.18A). During pathological examination, the 
biocompatibility of RC was confirmed. Any significant immune response presented by 
immune related cells was not found at 1 month and 6 month post-surgery.  At 1 month 
post-surgery, some keratocytes were found in the surrounding animal tissue and collagen 
fibrils connected the implanted RC to host rabbit tissue. However, the gap between the 
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host tissue and the reconstructed cornea remained. Integration between host tissue and the 
reconstructed cornea was completed before the 6 month time point post-surgery. 
However, no cells migrated into the reconstructed cornea until 6 months post-surgery 
(Figure 5.18B).  
5. 3. 7.  Anterior lamellar keratoplasty model 
To evaluate the potency of the shaped RC as a corneal substitute, a rabbit partial 
keratectomy model was conducted. The re-epithelialization in the RC implanted cornea 
was completed before 14 days post-surgery whereas that on the control cornea was done 
before 7 days post-surgery. Corneal neovascularization, graft degradation, immune 
rejection and other complications were not observed during the study. The initial 
thickness of corneas that received RC and the control cornea was 353.7 ± 10.3 µm and 
360µm respectively. A month later, RC treated corneas kept their thickness (360.8 ± 9.5) 
with RC. However, the control cornea was limited in its ability to regenerate its thickness 
(275 µm).  Although slight corneal haze was found in the RC implanted group during 30-
day period, corneal haze in the experimental group was not as serious as the control 
cornea (Figure 5.19). The pathological examination with H&E staining presented that the 
RC implanted cornea allowed cornea epithelial cells as well as keratocytes migration on 
and into RC respectively (Figure 5.20A). In addition, the migrated keratocytes remodeled 
the collagen structure of the RC (Figure 5.20B). In ultrastructural evaluation, the RC 
treated cornea had not fully integrated with host tissue until 1 month post-surgery. Some 
gaps between RC and host cornea were found in the interface. In addition, some 
keratocytes were found in the implanted RC. The collagen density of implanted RC was 




5. 4.  Discussion 
 An ideal xeno-originated corneal substitute for patients must have a similar 
composition and structure with the human cornea without containing animal 
immunogenic antigens. To address these requirements, the decellularized animal cornea 
aims to achieve two critical goals, maintaining composition and structure of the animal 
cornea while reducing animal cellular components. However, these goals are difficult to 
achieve together only using a decellularization procedure and a special strategy is needed. 
In the present study, we proposed an alternative strategy: to reconstruct the damaged 
corneal structure after harsh decellularization processes with our two novel procedures.  
To establish an optimal decellularization process, we evaluated three categories of 
decellularization methods: mechanical, chemical and enzymatic treatments in the present 
study. Chemical and enzymatic methods efficiently removed visible cells and their debris. 
However, mechanical methods could not efficiently reduce cellular contents. Chemical 
decellularization methods with SDS and Triton-X are well known to efficiently remove 
cells by solubilizing the cellular membrane [55, 147, 150-152].  However, these methods 
have several challenges including remnants of toxic agents and structural deformations of 
proteins after treatment [152]. Since vigorous washing steps and our novel reconstruction 
process address these problems, both processes were adopted in our combined 
decellularization protocol. Both enzymatic methods fully removed visible cells in the 
porcine cornea as previous studies [58, 153].  The mechanism of enzymatic 
decellularization is not clear yet. In addition, ironically, FBS has been widely used in 
conventional cell culture and does not damage the cells in this setting. However, the 
87 
 
enzymatic methods have already demonstrated their efficacy in destroying immunogenic 
DNA content after other decellularization processes [154, 155]. Although DNase 
treatment proved its potency, we selected FBS due to the efficiency considerations in our 
decellularization protocol after the optimization process. The mechanical treatments, 
except the high-hydrostatic pressure method, preserved the collagen structure of the 
cornea relatively well. However, the decellularization effect would be dependent on only 
mechanical changes of intracellular components and would not be enough to fully 
remove cells [58, 60, 152]. The results in the present study confirmed this. Although 
hypertonic solution may reduce a certain number of cells, the weak potency of 
mechanical methods was unable to efficiently reduce not only the cell number but also 
the amount of cell contents. Despite the great preservation of the corneal structure, the 
methods could not be selected in the present study due to the possibility of immune 
rejection after transplantation [62].  
 Transparency is a critical role of cornea as it is the window of eye. It is well 
known that a highly organized corneal structure maintains the transparency of the cornea 
[1] and hydration could be a good indicator of structural integrity [60]. In this study, we 
confirm that all decellularization methods significantly decreased corneal transparency. 
The decellularization process could also affect the structural integrity of cornea by 
destroying the function of the corneal endothelium.  When the endothelium loses its 
function, the water flux is not controlled which leads to structural alteration of the cornea 
represented by swelling and decreased transparency [1, 60]. The degree of structural 
alteration would be different depending on each decellularization method. However, all 
decellularization methods allowing flux of solution would not avoid the loss of 
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transparency. Application of dextran solution or glycerol could reduce the water content 
of cornea that may somewhat increase transparency of cornea [60]. However, without the 
reconstruction of corneal structure, it would be expected to rehydrate and be translucent 
after applying hypo to isotonic solution [156].  
 To address this issue, we applied our novel vitrification and riboflavin 
crosslinking procedures; the reconstruction process. Through self-organization of 
collagen structure during evaporation, the layer-by-layer structure was restored and 
confirmed through microscopic evaluation and the process reinforced structural stability 
represented by decreased hydration. The hydration, which represents  material stability 
and crosslinking density, is positively correlated with thickness [157] while negatively 
correlated  with light transmittance [121], stiffness [122, 123] and enzyme resistance 
[158].  After the decellularization process, hydration of the porcine cornea was 
significantly increased and decreased after the reconstruction process. Other corneal 
properties were also a function of destruction and restoration of material stability. 
 Transparency of the cornea was increased after the reconstruction process not 
only by restored material stability but also structural reconstruction. Light transmittance 
of the cornea increased with small-diameter collagen fibrils and low interfibrillar spacing 
which negatively correlated with fibril density [64, 116]. The restored layer-by-layer 
lamellar structure would explain how the reconstruction process increases transparency of 
cornea by structural restoration. However, increased fibril density and decreased collagen 
diameter in RC would also contribute to increased transparency of RC with alteration of 
collagen fibril structure. The light transmittance test and gross observation revealed a 
yellowish color from riboflavin was stained in RC which could be problematic. However, 
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the color was gone within 1 month after implantation in both animal models and we 
believe it would not cause significant visual problems after transplantation.  
The reconstruction process reorganized the corneal structure by reinforcing the 
strength of molecular bonding. Thermal stability represented by denaturation temperature 
indicates the amount of the molecular bonding interaction and inherent strength of the 
material which correlates with hierarchical tissue organization [159].  In this study, the 
denaturation temperature of RC cornea is significantly increased after the reconstruction 
process and comparable with that of the native cornea. It implies the material 
organization and inherent strength is restored after the reconstruction process which 
would benefit the microstructural stability.  
However, compressive modulus of RC was significantly higher than those of the 
native cornea and DC. This would result from increased crosslinking density, represented 
by decreased hydration, after the reconstruction process. The increased modulus indicates 
increased degree of material stiffness and brittleness that limits surgical handing, 
especially suture technique and handling the material with surgical forceps. However, in 
this study, we successfully applied interrupt sutures on RC without significant problems 
and there were no marks of indentation in the material from forceps during either surgical 
procedure. In addition, modulus of RC was not significantly different with that of human 
cornea in the previous study which was performed in the same conditions [64]. Thus, 
although compressive modulus was increased after the reconstruction process, the 
mechanical properties of RC could be acceptable as a corneal substitute for 
transplantation to patients.   
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After corneal transplantation, collagenase activity is essential to remodel tissue 
and promote wound healing [160, 161]. Collagenase resistance of materials is critical to 
maintain tissue stability after implantation [158].  However, if the material does not 
respond to collagenase, integration with host tissue could be impeded [161]. Thus, the 
material needs to have an appropriate response to collagenase to ensure successful 
implantation. The reconstruction process extended collagenase resistance time from the 
low collagen resistant DC by increasing material stability [162]. The extended but similar 
resistance time of RC compared to that of the native cornea may indicate the potential for 
good integration with host tissue.  
One of significant weaknesses of chemical decellularization is residual agent 
which is strongly cyototoxic and harmful in the implantation. In the present study, both 
RC and DC did not show cytotocitiy and allowed good proliferation of keratocyte-
induced fibroblasts. As shown in other studies [55, 147, 151], vigorous washing could 
remove enough detergent to ensure safety. In addition, DC and RC supported three types 
of cells when compared to the native cornea. Favorable biological properties of DC and 
RC indicate potential as cell carriers with customizable 3D shapes in various applications 
such as endothelial transplantation [163].  
Another important function of cornea is generating refractive index through its 
novel concave shape.  After structural deformation, the curvature of DC is altered which 
may not guarantee visual acuity after transplantation. Previously, we generated controlled 
3D shapes in CV [72] using a single mold. However, the portion of the implant which 
was not in contact with the mold had an uneven rough surface. The uneven surface may 
impede the epithelial migration after implantation which would lead to a delayed healing 
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process.  Our double molding method successfully generated a desirable concave shape 
with smooth surface on both side. In addition, the customizable 3D shape of RC could 
improve applicability compared to the flat cornea in the surgical room. In addition, our 
technique could generate patient-catered RC in the near future by generating various 
accurate curvature of RC through modifications of mold curvature.  
Implantation of the reconstructed cornea in two rabbit models showed good 
integration with host tissue and the implants remained transparent without any 
remarkable problems. In addition, the shaped RC allowed functional regeneration of 
epithelium in the anterior lamellar keratoplasty model. However, surprisingly, between 
the two animals, keratocyte behavior was different. The interlamellar implantation model 
did not allow keratocyte infiltration within the implant whereas anterior lamellar 
keratoplasty model supported cell migration within a month.  The migrated keratocytes 
into the implant may allow stromal remodeling by secreting various components 
including collagen GAGs [60, 164] that would be helpful during reconstruction of the 
wounded patient cornea. When remodeling the stromal layer, an important factor to 
activate keratocytes is a cytokine-mediated interaction between epithelial cells and 
keratocytes [60, 161]. The anterior lamellar keratoplasty induced epithelial cell damage 
whereas interlamellar keratoplasty did not. The lack of stimulating epithelial cell-induced 
cytokines may limit activation of keratocytes which may have resulted in the different 
behaviors of keratocytes between two animal models.  
In conclusion, we have successfully developed a xenotransplantable corneal 
substitute with micro and macroscopic reconstruction processes. The reconstruction 
process restored properties to the decellularized cornea and regenerated the corneal 
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concave shape.  The shaped RC was implanted into two rabbit models and presented the 
great potency of this material as a corneal substitute. In addition, the reconstruction 
methods may be able to contribute to the production of other corneal substitutes in the 






Figure 5. 1.  Schema for generating the concave shape of the reconstructed cornea. 
The concave mold following the contour of the rabbit cornea was made by PMMA (A). A 
decellularized cornea was place on the mold (B) and gentle pressure was applied to make 
the cornea conjunct with the surface of the mold (C). Vitrification was carried out for 2 
weeks (D) and then a few drops of 0.1% of riboflavin solution were applied within the 
mold (E). After incubating the cornea overnight in a cold room, UV light was applied for 
90 minutes each side (F). The mold was opened (G) and the shape reconstructed cornea 





Figure 5. 2.  The method to evaluate curvature of the shaped reconstructed cornea 
using an optical coherence tomography (OCT) imaging system. The system was set 
up with a swept source OEM engine, a balanced photo-detector (BD), a fiber coupler 
(FCP), polarization controllers (PCs), a fiber collimator (FC), a galvo-mirror (GM), a 
scanning lens (SL) and other components (A). Curvature of the reconstructed cornea and 
the mold was measured at two central, and four mid-central regions (indicating with 






Figure 5. 3.  Schematic feature of the procedure of interlamellar keratoplasty. After 
making an incision using 8mm Hessburg-Barron vacuum trephine about half the 
thickness of full cornea, lamellar dissection was performed to produce an intrastromal 
pocket with a crescent knife (A). After, a plat reconstructed cornea was inserted into the 
intrastromal pocket (B). The reconstructed cornea was placed in the middle of the stromal 






Figure 5. 4.  Evaluation of the efficiency of conventional decellularized methods for 
porcine corneas. Representative H&E staining of cornea (A, n=5) and Quantification 
analysis of the amount of residual DAN in porcine corneas (B) after treating by each 
decellularization process. * indicates p < 0.05 for difference versus the native cornea with 
Mann-Whitney test. Data in (B) are means ± SD (n=5). Red allows indicates residual cell 
debris in the corneal stroma. Scale bar, 100 µm. SDS: Sodium dodecyl sulfate, FBS: 




Figure 5. 5.  Alteration of transparency of porcine corneas after each 
decellularization process. Gross images (A) and quantitative light transmittance of 
porcine corneas (B) after treating with each decellularization process. * indicates p < 0.05 
for difference versus the native cornea with Mann-Whitney test. Data in (B) are means ± 
SD (n=5). Scale bar, 5mm. SDS: Sodium dodecyl sulfate, FBS: Fetal bovine serum. 
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Figure 5. 6.  Effects of the combine decellularization protocol (I).  Quantification of 
the amount of residual DNA (A), Immunoblot for β-actin (B) and light transmittance of 
representative wave lengths (C) in corneas. The sample from keratocyte extraction was 
used a control in the β-actin immunoblot.   * indicates p < 0.05 for difference versus the 
native cornea with Mann-Whitney test. Data in (A) and (C) are means ± SD (n=5). Nat: 
Native cornea, Cell: Keratocyte extraction, SDS: Sodium dodecyl sulfate treated cornea, 
S+T: SDS and Triton-X treated cornea, DC: Decelluarized cornea treated by SDS, Triton-






Figure 5. 7.  Effect of the combined decellularization protocol (II). Collagen (A) and 
glycosaminoglycan (GAG) contents of the native cornea and the decellularized cornea 
(DC). * indicates p < 0.05 for differences versus the native cornea with Mann-Whitney 






Figure 5. 8.  Effect of the reconstruction process for transparency of corneas. 
Representative images (A, n=5) and light transmittance in all visible wave length (B) of 
native, decellularized (DC) and reconstructed cornea (RC). In all wave lengths, light 
transmittance of the reconstructed cornea is significantly (p < 0.05  by Mann-Whitney 
test )higher and lower than that of the decellularized and the native cornea respectively. 





Figure 5. 9.  Macrostructural evaluation for native, decellularized and reconstructed 







Figure 5. 10.  Ultrastructural evaluation for native, decellularized (DC) and 
reconstructed corneas (RC). Representative transmission electron microscopy images 
(A, n=5), quantitative analysis of collagen fibril number in the defined area (B) and 
collagen fibril diameter (C) for corneas. * indicates p < 0.05 for difference between 






Figure 5. 11.  Characterization of corneas. Measurement of thickness (A) and 
hydration (B) of the native, the decellularized (DC) and the reconstructed cornea (RC). * 
indicates p < 0.05 for difference versus the native cornea with Mann-Whitney test. Data 






Figure 5. 12.  Thermal properties of corneas.  Denature temperature (A) and 
representative thermogram (B, n=5) of differential scanning calorimetry for native, 
decellularized (DC) and reconstructed corneas (RC). * indicates p < 0.05 for difference 







Figure 5. 13. Mechanical characterization and degradation profile of corneas. 
Compressive modulus (A) and collagenase degradation rate (B) of native, decellularized 
(DC) and reconstructed corneas (RC). * indicates p < 0.05 for differences between 
corneas with Mann-Whitney test. # means significant differences versus the native cornea 




Figure 5. 14.  Cytotoxicity analysis with Live/Dead cell staining for tissue culture 






Figure 5. 15.  Proliferation prolife of three corneal cell types on corneas. Proliferation 
rate of human corneal epithelial cells (A), human keratocyte-induced fibroblasts (B) and 
bovine corneal endothelial cells (C) on tissue culture plate (TCP), native, decellularized 





Figure 5. 16. Immunocytochemistry for human epithelial cells, human keratocyte 
and bovine endothelial cells on tissue culture plate (TCP), native, decellularized and 







Figure 5. 17.  Representative gloss feature, 3D and 2D optical coherence 






Figure 5. 18.  Intrastromal implantation of the reconstructed cornea (RC) for 
rabbits. Post-operative observation (A) and H&E stating (B) of the rabbit interlamellar 






Figure 5. 19.  Implantation of the reconstructed cornea (RC) into rabbits with 
anterior lamellar keratoplasty. External features and the re-epithelial process of the 
control (n=1) and the RC applied rabbit corneas (n=3) after the lamellar keratoplasty 






Figure 5. 20.  Pathological examination for the rabbit cornea implanted the 
reconstructed cornea (RC) with anterior lamellar keratoplasty. Images of H&E 
staining (A and B) and transmission electron microscopy (C) for the control (n=1) and the 
reconstructed cornea (RC) applied rabbit corneas (n=3) after the lamellar keratoplasty. 
Scale bar for (A) and (B): 100 µm. White arrow: A gap between the native cornea and 





Table 5. 1.  Information about antibodies.  





Primary Cytokeratine 3 Millipore 1:100 
Secondary 







Primary Keratocan Santa Cruz 1:200 
Secondary 















6. Nictitating membrane fixation improves stability of the 




6. 1.  Introduction 
Animal models are the primary tool to evaluate comprehensive physiological 
responses to biomaterials in the ophthalmic research. A proper animal model study is 
considered an essential procedure to ensure a successful translational application of an 
ophthalmic biomaterial to clinical use. However, the anatomical and physiological 
differences between humans and animals can preclude accurately capturing the anatomy 
and physiology of the human eye [165].  The nictitating membrane (NM), also termed the 
third eyelid, exemplifies species-specific differences of the eye. Anatomically, most 
animals have this accessory eyelid around the medial canthus, whereas human and 
anthropoids keep a vestigial remnant of this organ, plica semilunaris [166].  
Physiologically, the function of the plica semilunaris in human is insignificant, but the 
NM in animals contributes to a healthy animal eye by producing and distributing tears, 
removing ocular debris, secreting immune proteins, and acting as a mechanical barrier [2]. 
The NM can limit animal studies of a new biomaterial, as a soft or a vulnerable material 
applied on the ocular surface can be easily damaged by movement of NM. Additionally, 
if the material weakly binds to the ocular surface, it could be displaced and consequently 
removed from the animal by NM.   
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Contact lens application can be hindered by both limitations. Although the NM 
could help keep a contact lens hydrated, it also reduces stability of the contact lens, 
preventing further preclinical study [167]. To increase stability, nictitating 
membranectomy and tarsorrhaphy have been used to remove the membrane or limit 
movement, respectively. However, excision of NM is an invasive procedure, and could 
cause mild to moderate dry eye syndrome [168] which leads to pathological cascades on 
the ocular surface [169] in some species. Closure of the palpebral aperture by suturing 
both eyelids decreases oxygen levels [170, 171], alters tear fluid osmolality [172] and 
swells the corneal epithelium [167]. Thus, these surgical procedures cause undesired 
secondary effects resulting in distortion of data from the animal study.   
To improve upon existing models for preclinical biomaterials, especially contact 
lens research, we have developed a method to stabilize the nictitating membrane. By 
fixing the NM to the upper eyelid, the movement of the membrane can be limited which 
may lead to increased material stability on the ocular surface of animals. We evaluated 
the feasibility of NM fixation to improve material stability.  
 
6. 2.  Materials & Methods 
6. 2. 1.  Animals  
Twelve New Zealand white male rabbits, 2.0 to 3.5 kg in weight, were used in 
this study.  All experimental procedures in this study accord to the Association for 
Research in Vision and Ophthalmology (ARVO) Statement for the Use of Animals in 
Ophthalmic and Visual Research, and were approved by the Institutional Animal Care 
and Use Committee at Johns Hopkins University. Ten animals were used for tear and 
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contact lens stability tests, and two animals served for gross observation and pathological 
examination.  
6. 2. 2.  Nictitating membrane fixation 
Membrane fixation was performed under general anesthesia with ketamine (15 
mg/kg of body weight) and xylazine (2 mg/kg of body weight) delivered intramuscularly. 
NM fixation was applied to a randomly chosen eye and the other eye was untreated to 
serve as a control. After administering one or two drops of topical anesthesia 
(proparacaine 0.5%), a horizontal mattress suture using a 4-0 polyglactin 910 (Vicryl, 
Ethicon, Somerville, NJ) was placed between the free edges of the nictitating membrane 
and the upper eyelid. The suture needle first penetrated an ophthalmic spear cut 5 (length) 
x 10 (width) mm in size. Next, the suture was passed the upper eyelid through the 
palpebral conjunctiva in the medial canthus area (Figure 6.1A). The last suture was 
placed about 4-6 mm in length along the lateral margin of nictitating membrane, 
approximately 2 mm apart (Figure 6.1B).  The following suture bite was backed out the 
palpebral conjunctival and passed through the upper eyelid (Figure 6.1C) and the 
ophthalmic spear (Figure 6.1D). The suture knot was made on the spear (Figure 6.1E), 
and the spear was trimmed to stay within the margin of the eyelid.  
6. 2. 3.  Schirmer tear test and tear break-up time 
To assess the change of quantity and quality of tear production after the NM 
fixation procedure, Schimer tear test-1 (STT-1) and tear break-up time (TBUT) 
measurements were performed for both eyes (n = 10 rabbits) 6 hours after the surgery, 
and at days 1, 2 and 3. After bending the notch of a STT strip (Alchon®, Fort Worth, TX), 
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the folded end was placed within the inferolateral one-third of the lower conjunctival 
fornix for 3 minutes. The level of tear migration was marked and measured from the fold, 
immediately at removal. TBUT was assessed under blue light in a dark room.  Each 
eyelid was closed manually to distribute the tear film. Then, the eye was held open and 
two drops of sodium fluorescein dye (Fluoresoft -0.35%®, Alden optical, Lancaster, NY) 
were added onto the corneal surface. The time for observing distortion of the reflected 
image was recorded.  
6. 2. 4. Contact lens stability test 
After the tear tests, rabbits underwent contact lens stability tests. Each contact 
lens (Hydrokone®, Visionary Optics, Front Royal, VA) was confirmed to fit each eye 
with the conventional contact lens fitting method using florescent dye and a slit lamp 
microscope. The base curvature and the diameter of lens were 8.4-8.6 and 14.00 mm, 
respectively. We measured stability of the contact lens by calculating the rate of 
“successful retention”, which was defined in this study as the contact lens remaining on 
the corneal surface for more than four hours after application. The contact lens was 
applied four times per an animal. 
6. 2. 5. Gross observation and pathological examination 
Two rabbits not used for either tear or contact lens tests were observed for one 
month after NM fixation. At 1 and 2 weeks and 1 month after the procedure, each eye 
was examined with a conventional slit lamp microscope. After 1 month, the rabbits were 
sacrificed for pathological examination. The tissue was collected from the eye that 
underwent the procedure and the collateral eye served as a control. Dehydrated and 
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paraffin-embedded sections were stained with hematoxylin and eosin (H&E) using 
standard techniques.   
6. 2. 6. Statistical analysis 
Data from tear tests (STT values and TBUT) were presented as means ± standard 
deviation (S.D.). Results were analyzed by Mann-Whitney test to evaluate the differences 
between two eyes at each time point using SPSS 15.0 for Windows (SPSS Inc., Chicago, 
IL). Statistical significance was established at p < 0.05.  
 
6. 3.  Results 
6. 3. 1. Tear tests 
To evaluate secondary effects for the secretary system after NM fixation, we 
tested tear production quantity and quality. No significant differences of STT values and 
TBUT measurements were found between the control and experimental eyes. In the fixed 
eyes, the average STT value was 10.1 ± 2.0 mm 6 hours after the procedure on day 0 
(Figure 6.2A). The values for both eyes were consistent through the three-day experiment, 
ranging from 9.5 to 10.2 mm. The TBUT in both groups also did not fluctuate 
significantly over the course of 3 days after NM fixation, ranging from 31.5 to 33.9 
seconds (Figure 6.2B). Thus, the NM fixation procedure did not change the quantity and 
quality of tear production.  
6. 3. 2. Contact lens stability test 
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Both contact lens curvatures of 8.4 and 8.6mm fitted well on the all rabbit corneas. 
The stability of contact lens was increased after applying NM fixation, where the rate of 
contact lens retention—considered to be the lens remaining on corneal surface after 4 
hours— in the rabbit eyes that had procedure was higher than untreated eyes (90% versus 
42.5%, respectively).  
6. 3. 3. Gross observation and pathological examination 
During the course of 1 month after NM fixation, we observed no substantial 
lesions, including corneal haze, conjunctival hyperemia or chemosis, aqueous flare, or 
iris lesions in the both untreated and NM-fixed eyes (Figure 6.3). Normal Purkinje image 
was found in the both sets of eyes during this time period. Corneas from both untreated 
and fixed eyes did not show any remarkable pathological lesions upon H&E staining. 
Additionally, Mason’s trichrome staining confirmed there was no scar tissue formation in 
either eye (Figure 6.4).  
 
6. 4.  Discussion 
 The nictitating membrane can destabilize contacts lens on the animal eye, and 
thus be problematic when using animal models to reliably study the effect of new 
biomaterials on the corneal surface. The nictitating membranectomy is considered an 
essential procedure for contact lens retention in animal models [173]. However, the 
procedure is invasive and requires a relatively long surgical time, approximately a week 
of recovery, and additional surgical procedures, such as a cauterization. In addition, the 
surgery causes excessive tissue damage and presents ethical issues. We therefore 
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explored a new safe, simple, and non-invasive surgical approach that “fixes” the NM, in 
rabbits. The procedure and recovery time for NM fixation was minimal, and only brief 
training would be needed to use basic surgical instruments. In addition, the buffer effect 
of the ophthalmic spear prevents laceration or necrosis of the upper eyelid by excessive 
tension of the suture knot, one of the most common complications during NM fixation to 
the upper eyelid [174]. 
Another issue of the nictitating membranectomy is the unavoidable excision of 
the accessory lacrimal gland. Although some animals can compensate for decreased tear 
production through other lacrimal glands and the harderian gland after removing the NM 
[175], animal models such as dogs and cats are susceptible to dry eye syndrome [176, 
177]. In addition, decreased tear production may affect contact lens retention by reducing 
hydration of soft contact lenses [170, 178]. Loss of goblet cell clusters in the nictitating 
membrane could decrease the mucin portion of tears, detracting from tear quality [166]. 
NM fixation does not require functional tissue manipulation of the NM, including the 
accessory gland, and a suture could induce only minimal tissue damage on the margin of 
NM and upper eyelid. We confirmed through STT and TUBT that the NM fixation 
procedure did not affect the quality and quantity of tears in rabbits. Furthermore, the 
procedure did not cause any substantial secondary morphological or pathological side 
effects at 1 month resulting from decreased quality and quantity of tear production.  
As shown in the rabbit model, we expect that NM fixation would increase 
retention of the contact lens on the cornea and be feasible for testing various contact 
lens–based technologies, such as the drug-releasing contacts for the glaucoma treatment 
[179]. In addition, this technique could be used in veterinary practice. For instance, the 
121 
 
loss of the bandage contact lens on the corneal surface can be an issue when treating 
animals with chronic corneal epithelial defects, such as dogs [180]. Because NM fixation 
was performed under the general anesthesia, some issues, such as the anesthetic risk, 
could be raised in the veterinary practice. However, the procedure could be done with 
auriculopalpebral nerve block, topical anesthesia of the eye, and infiltration anesthesia as 
being done in the NM flap [174] that could be reduce issues of the general anesthesia. 
Besides contact lenses, NM fixation could be used for the application of soft biomaterials, 
such as fibrin glue, to the animal cornea. The restricted movement of NM may reduce 
damage to and promote retention of the soft material.  
In conclusion, we demonstrated that NM fixation could increase stability of the 
contact lens without reducing the quality and quantity of tear production in healthy 
rabbits. In addition, the technique is simple and did not cause any major pathological 
changes. We suggest NM fixation would be helpful to design animal studies for 
investigating new contact lens and has potential to apply to other biomaterial research at 




Figure 6. 1.  Surgical procedure for nictitating membrane (NM) fixation. (A) After 
penetrating a tailored ophthalmic spear, the needle passed the upper eyelid through the 
palpebral conjunctiva. (B) A bite was made on the lateral part of the NM. (C) The 
followed bite was back out the palpebral conjunctival and passed through the upper 
eyelid. (D) Lastly, the needle penetrated the ophthalmic spear. (E) The suture was knotted.  





Figure 6. 2.   Evaluation of tear quantity and quality. Rabbits underwent NM fixation 
in one eye, while the other was left untreated as a control on day 0. (A) Shimer tear test 
(STT). (B) Tear break-up time (TBUT) measurement. Data are averages ± SD (n = 10). 
No significant difference was found between both groups of STT values and TUBT 






Figure 6. 3.  Gross observation for untreated and NM-fixed eyes. Two rabbits were 
examined both eyes, looking for lesions such as corneal scar and conjunctival redness 
during 1-month period. There were no substantial lesions in both eyes. Images are 





Figure 6. 4. Pathological examination for experimental and control corneas. Corneas 
were stained at 1 month with H&E and Masson’s trichrome. Corneas from both untreated 
and fixed eyes did not show any remarkable pathological lesions. Images are 







7. Evaluation of the biocompatibility of regenerated cellulose 







7. 1.  Introduction 
Ocular injury in the battlefield is considered to be more prevalent and more severe 
than in the civilian setting [181]. Prompt emergency treatment for ocular injury is 
essential to preserve vision, reduce pain and prevent secondary infection [72]. A bandage 
contact lens has the benefits of both treating and protecting the injured eye without 
compromising vision. Studies have shown the use of a bandage contact lens can relieve 
pain and photophobia in the mild to moderate ocular injury [182] and may promote 
healing of self-sealed perforations in more severe injuries [94]. Additional benefits of a 
bandage contact lens are the ease of application, particularly in a battlefield setting, and 
injury monitoring without removal.  
Use of natural polymers for biomedical applications is increasing as these 
materials are thought to possess properties better tailored to living organisms than 
synthetic materials [183]. Cellulose, the most abundant natural polymer, produced not 
only by plants but also by bacteria (e.g., Acetobacter), algae, and fungi, has found 
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widespread use as a material for biomedical applications [184]. Plant cellulose has long 
been used in the form of cotton for wound dressings and sutures [183], and is also widely 
used as a binder in pharmaceutical tablets [185]. Additionally, contact lens conditioning 
solutions containing hydroxyethylcellulose have shown improved wetting of lenses and 
enhanced lens wearing comfort [186]. One drawback to plant-based cellulose is that it 
requires intensive processing to separate it from the lignin and other materials in the plant 
bulk before it can be used. Bacterial cellulose (BC), although identical to plant cellulose 
in chemical structure, is excreted as a biofilm [184] of pure cellulose, which requires little 
processing before use. BC is remarkable for its high water content and mechanical 
strength; however, large-scale production remains challenging [183].  
Moisture management is critical to wound healing [187]. Poor moisture control of 
the wound environment impairs the healing process and increases the risk of infection 
[188]. Cellulose, both crystalline and BC, has unique moisture management 
characteristics [189] and several commercially available products take advantage of these 
characteristics. For example, Refresh Tears® an ophthalmic solution used to alleviate dry 
eye, contains carboxymethylcellulose (CMC) because it closely resembles the 
composition of natural tears [190]. Microbial cellulose marketed as Xcell® and used as a 
dressing for burn wounds, has been shown to effectively absorb exudate and hydrate dry 
areas of a wound, maintaining a moisture-balanced wound environment [191]. Given the 
above examples, cellulose-based materials seem ideal for ocular bandage applications, 
where adequate moisture on the ocular surface is critical for conjunctival and corneal 
wound healing.  
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Hydrogels are three-dimensional crosslinked polymeric networks with the 
capacity to hold water within the porous structure [192]. Developed and studied for use in 
a variety of biomedical applications, hydrogels from natural polymers, including 
cellulose, are of particular interest because of their hydrophilicity, biocompatibility, and 
biodegradability [193]. Hydrogels derived from plant cellulose and its derivatives show 
promise for many in vivo applications including drug delivery, wound healing, and cell 
transport [194-196].  Bacterial cellulose has been widely studied for use in wound healing 
and drug delivery, as well as tissue engineering, because of its high mechanical strength 
[191, 197-199]. In general, hydrogels are biocompatible because their hydrophilic surface 
has a low interfacial free energy when in contact with bodily fluids, which results in a 
low tendency for proteins and cells to adhere to these surfaces [200]. Plant-based and 
bacterial cellulose hydrogels have shown good biocompatibility [201, 202]. Thus, 
cellulose-based hydrogels have the potential to be used for therapeutic purposes for 
corneal injuries and diseases. 
 In our previous study [181], we demonstrated that the optical transparency and 
mechanical strength of hydrogels synthesized from different cellulose sources (plant, 
cotton, and bacterial) could be optimized within the range of contact lens material 
properties by tailoring synthesis parameters. The objective of this study was to evaluate 
the in vivo biocompatibility and related physical properties of the optimized cellulose-
based hydrogels and to demonstrate that these hydrogels could be made with contact lens 
geometry for potential use for corneal applications.   
 
7. 2.  Materials & Methods 
7. 2. 1.  Material preparation 
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Regenerated cellulose hydrogels were prepared as reported previously [181]. 
Briefly, for the plant-based celluloses, Avicel PH 101 (denoted herein as Avicel 101, 
FNC Biopolymer) or Cellulose (denoted herein as MCC4, Sigma-Aldrich 435236), 5 g of 
as-received cellulose powder was activated in 100 mL N,N-dimethylacetamide (DMAc, 
Sigma-Aldrich) with stirring at 350 rpm for 24 hours. Following this, dissolution was 
initiated by addition of 8 g of lithium chloride (LiCl, Sigma-Aldrich) with continued 
stirring at 350 rpm and heating to 95 °C until the solution became clear.  The resulting 
solution was then poured into the desired mold and allowed to gel; after which, the 
samples were gently washed in water to remove the excess LiCl/DMAc and stored in 
water prior to testing. For the bacterial cellulose, the as-received pellicle (prepared in-
house [181]) was dried by heat pressing at 45 °C under 14 MPa pressure for 5 minutes 
using a Carver Press (Hydraulic Unit Model #3912) followed by an overnight dry in a 
90 °C convection oven. Five hundred milligrams of the resulting dry sheet was placed in 
100 mL of 8% LiCl/DMAc solution and stirred at 500 rpm until the cellulose dissolved 
(up to 10 days). The resulting BC/LiCl/DMAc solution was then poured into the desired 
mold, gelled, washed, and stored in the same manner as described for the plant-based 
cellulose varieties.  
7. 2. 2.  Oxygen permeability 
A polarographic method was used to measure the oxygen permeability, Dk, of the 
hydrogels (Figure 7.1A). Polarography measures the oxygen permeation through a 
sample by measuring the current produced in a cell by reducing oxygen at a noble metal 
electrode [203-205]. Polarography is used to measure oxygen transmissibility, Dk/t, in 










). The oxygen 
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permeability can thus be calculated by multiplying the oxygen transmissibility by mean 
thickness of the material. A flat polarography cell was obtained from Rehder 
Development Corporation with a 4-mm outer diameter (O.D.), 24-karat gold cathode 
surrounded by a 5.75-mm inner diameter (I.D.), 12.50-mm O.D., pure silver anode. The 
polarography cell was calibrated using three rigid gas permeable reference materials with 
known oxygen permeability (Table 7.1) [206].  
For each reference material, the sample thickness was measured with a thickness 
gage (Starrett model #1015MA) and then placed onto the surface of the electrode/cell and 
fixed in place by gently pressing toward the electrode. The system was held in a humidity 
chamber at 35 ˚C with high humidity (> 90 %RH). A saline solution (0.9 % NaCl, pH 
7.4) was poured into the reservoir. A Keithley 2400 source-meter (source 0.75 V across 
the Au-Ag electrodes) was used to measure the electric current. Measurements were 
performed when the conditions described above were reached. The saline solution and 
the sample were then saturated with nitrogen to remove the oxygen. After the oxygen was 
removed and the current was nearly zero, air was bubbled through a glass frit into the 
solution. The increase in electric current was observed as the oxygen molecules reacted 
with the cathode. The current was recorded until it reached a stationary state. For each 
reference material, four different thicknesses were tested; thicker samples were achieved 
by stacking individual samples [204]. The determined offset between measured and 
reference values was utilized for the correction of the oxygen permeability of the 
hydrogels. The electric current was measured for several sets of hydrogels at various 
concentrations and the oxygen permeability was calculated from the slope of the linear 
regression plot of the edge-corrected resistance (t/Dk) versus the sample thickness (t) 
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[207] and corrected using the calibration equation developed from the standard materials 
(Figure 7.1B and C). The above process was followed for all hydrogels and a minimum 
of four different thicknesses were tested. 
7. 2. 3.  Endotoxin evaluation 
In order to assess the pyrogenicity of the regenerated cellulose-based hydrogels, 
samples were sent to Lonza Walkersville, Inc. (Walkersville, MD) for Kinetic-QCL® 
(KQCL) testing. The assays were conducted in adherence to USP <85> Bacterial 
Endotoxin Test and Lonza’s Quality System requirements and included a β-G-Blocker. 
Testing was performed according to Lonza standard operating procedures (SOPs) 162.6 
and 162.16. 
The KQCL assay is a quantitative, kinetic assay for the detection of Gram 
negative bacterial endotoxin and is intended as an in vitro end-product endotoxin test for 
human medical devices, drugs and other biological products. Briefly, a sample is mixed 
with the Limulus Amebocyte Lysate (LAL)-chromogenic substrate reagent, placed in an 
incubating microplate reader, and automatically monitored over time for the appearance 
of a yellow color. The reaction time is inversely proportional to the amount of endotoxin 
present and the concentration of endotoxin in unknown samples can be calculated from a 
standard curve [208]. The β-G-Blocker blocks the reactivity of LAL to β-1,3-Glucans, 
conferring increased endotoxin specificity to the LAL test and is intended as an adjunct 
for the KQCL assay [209].  
7. 2. 4.  Contact lens geometry 
In order to test the hydrogels for ocular applications, a method of molding the 
hydrogels with contact lens geometry was developed [210]. A metal contact lens mold 
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was fabricated using measurements for the mean radius of curvature of the rabbit cornea 
found in the literature (7.26 ± 0.26mm) [211] and a sample plastic optical contact lens 
mold (Eyegenix™). 
7. 2. 5.  Animals  
A total of four 6–week old female Sprague-Dawley rats and four male New 
Zealand white rabbits, approximately 3.5 kg in weight, were used in this study. All 
experimental procedures were approved by the Institutional Animal Care and Use 
Committee at Johns Hopkins University (JHU IACUC) and Animal Care and Use 
Review Office (ACURO) at the US Army.  
7. 2. 6.  Rat subcutaneous implantation model 
The rat subcutaneous implantation is a reliable animal model used to evaluate the 
biocompatibility, including immunogenicity and cytotoxicity, of biomaterials [212, 213]. 
Three different types of cellulose-based hydrogels (Avicel 101, bacterial, and MCC4) and 
a conventional balafilcon A contact lens (PureVision plus
®
, Bausch & Lomb, Rochester, 
NY) were implanted to the rat subcutaneously. Under inhalation anesthesia with 
isoflurane (Forane, Baxter, Deerfield, IL), the hair on the back was clipped and the skin 
disinfected with a povidone-iodine swap stick and 70% alcohol by turns three times. 
After applying a surgical drape, two 1.5-mm incisions were made on the back of rats. 
Blunt dissection was performed to undermine the skin and each of the three hydrogel 
samples (8 mm diameters) was implanted under the skin pocket created. The incision was 
closed by a 4-0 nylon suture and the rat was placed on a hot pack until fully recovered. 
Two rats were sacrificed at both 3 and 7 days after surgery and the implanted hydrogel 
sample and its surrounding tissue were collected under aseptic techniques. Sections (5-
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µm) of dehydrated, paraffin-embedded specimens were stained with hematoxylin and 
eosin (H&E) according to standard methods. 
7. 2. 7.  Rabbit ocular irritation study 
Owing to the specificity of ocular environments, an additional ocular 
biocompatibility study based on the ISO 9394 (Ophthalmic optics- contact lens and 
contact lens care products- Determination of biocompatibility by ocular study with rabbit 
eyes) procedure [214] was conducted with a modified abrasion test. All procedures 
follow the Association for Research in Vision and Ophthalmology (ARVO) Statement for 
the Use of Animals in Ophthalmic and Visual Research.  
To ensure each rabbit eye was free from ocular irritation, three days before 
starting the test an initial ophthalmic examination was performed using a slit lamp. In 
addition, to minimize the dislocation over the daily treatment period, nictitating 
membrane fixation and contact lens fitting were performed. The nictitating membrane 
was fixed on the upper eyelid under general anesthesia with ketamine (15 mg/kg–body 
weight) and xylazine (3 mg/kg–body weight) administered intramuscularly. The lens 
fitting was conducted with a fluorescent dye. After applying the experimental and control 
contact lenses (Hydrokone®, Visionary Optics, Front Royal, VA) respectively, a few 
drops of fluorescein dye were administered and the corneas examined under blue light to 
assess the staining pattern. In addition, to evaluate the possibility of corneal damage by 
the contact lens, an abrasion test was followed for each animal. After applying the contact 
lens, the contact lens was rubbed in a circular fashion about fifty times, and fluorescein 
dye was used to determine the presence of any resulting corneal abrasion.    
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After three days, the ISO 9394 procedure was performed. The ISO 9394 is a 
standard biocompatibility test for the evaluation of both novel contact lens material and 
contact lens care products. By applying a device to the rabbit eyes daily over 22 days, the 
degree of ocular irritation was evaluated. The experimental hydrogel and the control 
contact lens were applied to the left (cellulose hydrogel) and right (control) eyes of the 
each rabbit for 7 hours per day. After applying the lenses for 7 hours, the contact lenses 
were cleaned and kept in conventional lens solution. All animals were monitored hourly 
for dislocation of the lens and any evidence of stress by examining their behavior. If a 
lens displaced during the treatment period, it was rinsed with a conventional lens solution 
and reapplied. The rabbit eyes were examined using a Draize scoring system daily just 
prior to lens removal. On days 8, 15, and 22 days after lens removal, using a slit lamp 
biomicroscope, an eye examination, including florescent dye staining, was performed and 
scored with the McDonald-Shadduck system [214].  
After the eye examination on day 22, rabbits were sacrificed for pathological 
examination. In addition, for the positive control, four native adult rabbit cadaver eyes 
were obtained from Pel-freez biological (Rogers, AR). Sections (5 µm) of dehydrated, 
paraffin-embedded specimens were stained with hematoxylin and eosin (H&E), Masson’s 
trichrome, and Periodic acid–Schiff (PAS) according to a previous study [215]. 
 
7. 3.  Results and Discussion   
7. 3. 1.  Oxygen permeability of cellulose-based hydrogels 
The cornea is avascular and depends on external oxygen sources for cellular 
respiration [203]. For awake humans, the main source of oxygen to the cornea is from the 
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atmosphere, whereas during sleep it is from the palpebral conjunctiva or back of the 
upper eyelid [203]. Metabolic changes in the corneal epithelium are induced if the cornea 
does not receive adequate oxygen.  Therefore, contact lenses, particularly those worn 
overnight, need to have sufficient oxygen permeability. Researchers have proposed 
widely varying minimum transmissibility values for contact lenses to prevent corneal 
hypoxia and limit corneal edema, ranging from 15 to 125 barrer/cm [204]. The oxygen 
permeability of commercial contact lenses depends on the component materials, but is 
generally in the range of  26-175 barrer/cm, which  provides enough oxygen to the cornea 
to prevent problems, depending on the wear duration [216]. 
The oxygen permeability of cellulose hydrogels prepared from varying 
concentrations (2 to 5%) of Avicel 101 crystalline cellulose was characterized along with 
hydrogels from 5% MCC4 and 0.5% BC (Table 7.2). The results suggest that as cellulose 
concentration increases, the oxygen permeability decreases. This is expected as the 
oxygen permeability is impacted by the water content of the hydrogels [217] and we 
previously showed that the water content of the cellulose hydrogels decreases with 
increasing cellulose concentration [218].  All the hydrogel samples were found to have 
oxygen permeability in the range of that of commercially available contact lenses (~55-
115 barrer). The 95% confidence limits were  likely impacted by  thickness asymmetries 
in the individual hydrogel samples, which would lead to less precise thickness 
measurements for the Dk/t calculations as well as amplify the boundary effects during 
stacking of the thicker samples. In addition, the wide 95% confidence limits around the 
BC oxygen permeability were likely due to small remnants of the BC pellicle left behind 
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by the incomplete dissolution of the pellicle, which would have yielded less uniform BC 
hydrogels; similar results were observed with a second lot of BC hydrogels.  
7. 3. 2.  Endotoxin in cellulose materials 
Endotoxin, a component of the cell wall in Gram-negative bacteria, can cause 
adverse reactions in humans if present in drugs or medical devices. The general U.S. 
Food and Drug Administration (FDA)–recommended limit for endotoxin in medical 
devices is <0.5 endotoxin units (EU)/mL (based on a 40-mL rinse) [219]. Endotoxin tests 
performed on the as-received cellulose starting materials and their resulting hydrogels by 
an accredited laboratory, Lonza Walkersville, Inc., showed that the plant-based cellulose 
starting materials have an acceptable level of endotoxin for medical devices (<0.5 EU/mL) 
(Figure 7.2); however, the endotoxin level of the resulting hydrogels from these materials 
was above the acceptable limit, though within a reasonable range for in vivo testing [220].  
It was hypothesized that handling of the hydrogels during synthesis was 
introducing endotoxins and that making small improvements to the synthesis procedures 
would reduce the endotoxin levels. Thus, important changes were made to the synthesis 
procedure: 1) use of depyrogenated glassware; 2) use of sterile, filtered deionized water 
(0.2-μm filter); and, 3) use of a laminar flow hood. These simple changes resulted in a 95% 
reduction in endotoxin level compared with the original hydrogel preparation. Further 
reduction to acceptable levels (Figure 7.2) was achieved by implementing aseptic cell 
culture techniques [221].  
The hypothesis that unsterile handling of the hydrogels was causing increased 
endotoxin levels was tested after each modification to the synthesis procedure using 
hydrogels prepared from Avicel 101. Since the endotoxin levels decreased with each 
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synthesis modification, it was inferred that handling was the dependent variable and that 
the endotoxin level of the hydrogels was independent of cellulose type, so further 
endotoxin testing was not done for the other plant-based materials.  
For the bacterial cellulose, the endotoxin level of the hydrogel (108 EU/mL) was 
lower than the level for the as-received pellicle (354 EU/mL). It was hypothesized that 
the incomplete removal of the cellulose generating bacteria was the cause. Additional 
washing procedures were implemented for the BC pellicle [222-224], which succeeded in 
lowering the endotoxin level of the starting material by 90% (34.6 EU/mL). Though not 
below the <0.5 EU/mL threshold, it was within a reasonable range to continue with in 
vivo testing [220] given the trend of the hydrogel having lower endotoxin levels than the 
starting material, along with the improved endotoxin levels for the plant-based cellulose 
hydrogels after implementation of aseptic handling procedures described above.  
Additional techniques to reduce the endotoxin levels will be explored for any future 
testing with BC hydrogels.  
7. 3. 3.  Rat subcutaneous implantation model 
The implants all showed acute inflammation with increased number of immune 
cells at the 3- and 7-day time points (Figure 7.3).  In addition, inflammation surrounding 
cellulose implants was more severe than that of conventional contact lenses soon after 
implantation, but less severe than the contact lens group at day 7. This suggests that all 
cellulose implants cause a moderate acute immune response but are tolerated by the host 
tissue over time. When compared to the conventional contact lens, all three types of 
cellulose showed acceptable biocompatibility. 
7. 3. 4.   Contact lens geometry and rabbit ocular irritation study 
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Based on the high oxygen permeability (Table 7.2), acceptable endotoxin level, 
and in vivo biocompatibility results, Avicel 101 was selected as the cellulose source for 
the hydrogel lenses. Contact lens–shaped hydrogels were successfully prepared from a 5% 
Avicel 101 solution, using modified aseptic synthesis procedures described above, and a 
lens-shaped mold (Figure 7.4A). Preliminary fit tests were done using an adult rabbit 
cadaver eye and showed that the geometry of the lens was appropriate for further in vivo 
testing (Figure 7.4B).  
Owing to the specificity of the ocular environment, the degree of ocular irritation 
in rabbits was investigated according to ISO #9394. An initial ophthalmic examination 
showed all eyes were clear of ophthalmic problems. It has been well established that poor 
fitting contact lenses cause irritation, discomfort, decreased contact lens stability, and 
could be associated with ocular problems, including limbal hyperemia and corneal 
staining [225]. Because poor lens fitting could distort the results of the irritation study, 
creating a contact lens which fits the contour of rabbit cornea was essential.  The shaping 
procedures developed during this work successfully generated cellulose contact lenses 
with curvature corresponding to the contour of rabbit cornea, as did the control contact 
lens. The fitting test with fluorescein dye proved that both control and experimental 
contact lenses had proper curvature without any lifting areas or bubbles under the contact 
lens (Figure 7.4C).  
Cellulose contact lenses did not cause corneal abrasion, as indicated by corneal 
staining with fluorescein (Figure 7.4D and E). During the irritation study with ISO 9394, 
the rate of lens retention, i.e., no dislocation during the 7 hour application time was 90.9% 
for cellulose contact lenses and 68.1% for control lenses. The McDonald-Shadduck 
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scores for slit lamp biomicroscopy are presented in Table 7.3.  Despite some mild 
symptoms, all eyes were within normal variations (Figure 7.4F). No serious lesions, 
including corneal ulcer, corneal haze, conjunctival chemosis, aqueous flare, or iris lesions 
were found in either group. Throughout the study, only mild (Score 1 out of 4 on Draize 
scale) conjunctival redness (Figure 7.4G) and ocular discharge (Figure 7.4H) were found 
in the gross ocular examination. However, the cellulose contact lens groups showed 
redness and discharge more frequently than the control group (Table 7.4).   
The pathological examinations confirmed mild irritation caused by both the control and 
experimental contact lenses. There was no evidence of an inflammatory response or toxic 
effects in either the experimental or control corneas. Additionally, Masson's trichrome 
and PAS staining proved corneas from both groups did not include scar tissue formation 
in the stromal layer and there was no abnormal glycogen metabolism around the corneal 
epithelium (Figure 7.5). However, five to seven layers of moderate hypertonic epithelium, 
representing irritation of the corneal surface, were found in the cellulose contact lens 
group, whereas four to five layers of mild hypertonic epithelium were found in the 
control group (Figure 7.5). This may have been a function of the cellulose lens fitting too 
tightly against the corneal surface, something that could be easily corrected. 
 
7. 4.  Conclusions 
Cellulose hydrogels with optimized material properties, including high oxygen 
permeability and low endotoxin levels, were synthesized using aseptic methods. In rats, 
the hydrogels were biocompatible. Cellulose hydrogels with contact lens geometry were 
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successfully tested in vivo and showed no evidence of material toxicity after daily wear 
for 22 days. Although further refinements to the contact lens fit will be needed to reduce 
irritation and redness, we have established biocompatibility of the cellulose hydrogels. 
Future investigations will be twofold. First, while BC does not seem ideal for ocular wear 
at this time, given its healing benefits, additional synthesis options will be investigated in 
attempts to optimize the oxygen permeability and other properties for this application. 
Second, the healing efficacy of the cellulose hydrogels will be studied; if healing efficacy 
is shown, cellulose hydrogels have the potential to not only be used as a bandage material, 
but may provide a platform for drug delivery, which has been challenging with currently 




Figure 7. 1.  Oxygen permeability measurements.  A) Diagram of the polarographic 
cell used with components labeled. B) Best fit linear equation derived from the measured 
and established standard Dk values of the rigid gas permeable reference materials from 
which the oxygen permeability of the samples was calibrated. C) Representative best fit 
linear regression plot of the edge-corrected resistance (t/Dk) versus sample thickness (t) 






Figure 7. 2.  Bacterial endotoxin level for cellulose-based hydrogels. Data are from 
Avicel 101 at different preparations, showing the decrease in endotoxin level after 





Figure 7. 3.  Pathological examination of material implanted rats. Images of H&E-
stained implants and surrounding tissue are shown. Commercial balafilcon A contact lens, 
Avicel 101, BC, and MCC4 hydrogels were implanted and analyzed 3 days (D + 3) and 7 





Figure 7. 4.  Hydrogels with contact lens geometry and in vivo ocular irritation study. 
A) Contact lens shaped mold. B) Contact lens hydrogel fit-tested using a cadaver rabbit 
eye. C) Contact lens hydrogel fit-tested in live rabbit. D) & F) Abrasion test of the 
cellulose hydrogel lens (D) and control (E). F) – H) Representative pictures of rabbit eyes 
in the cellulose contact lens group with no lesions (F) and  mild conjuctival redness (G) 
without the cellulose contact lens, and mild ocular discharge (H) denoted by red arrow 




Figure 7. 5.  Pathological examination for the native cornea, cellulose-derived and 
conventional contact lens (control) applied corneas. Tissues were stained with H&E, 





Table 7. 1.  Oxygen permeability measured for rigid gas permeable reference 
materials. The permeability values (Dk) are the inversion of the slope from the 
corresponding edge-corrected resistance (t/Dk) versus sample thickness (t) linear 
regression plot of the number of thicknesses tested (N) for each material. The measured 
Dk was plotted against the established Dk value[206] and used to develop the calibration 











Silafocon A 4 8.3 8.8 
Itafluorofocon A 4 45.4 51.8 




Table 7. 2. Oxygen permeability and confidence limits for regenerated cellulose 
hydrogels. The permeability values (Dk) are the inversion of the slope from the 
corresponding edge-corrected resistance (t/Dk) versus sample thickness (t) linear 
regression plot of the number of thicknesses tested (N) for each material. The confidence 
limits were derived from ±2 standard deviations surrounding the slope of the regression 










2% Avicel 101 4 115.2 92.6 - 150.5 
3% Avicel 101 5 101.8 98.5 - 105.2 
5% Avicel 101 5 95.9 83.9 - 111.1 
5% MCC4 4 86.0 71.3 - 107.1 




Table 7. 3. Ophthalmic observation by slit lamp biomicroscopy with the McDonald-
Shadduck score system.  Data reported are the number of eyes that present ocular lesion 
(i.e. either conjuctival congestion or discharge) on day 8, 15 and 22 (n=4 per group). 
Except mild conjunctival congestion and discharge, other responses were not found.   
Response Day  
Cellulose group  
  (number of eyes ) 
Control group ) 
(number of eyes ) 
Conjunctival congestion 
(Score 1) 
8 1 2 
15 4 0 
22 1 0 
Conjunctival discharge 
(Score 1) 
8 2 2 
15 3 1 






Table 7. 4. Gross ocular observation by the Draize Scale. Data presented are the 
frequency of finding for eye responses (conjunctival redness and discharges) for 22 days 
(n=4 per group). Except conjunctival redness and discharge, other responses were not 
found during the experiment.  
  
Response 
Cellulose group (times 
for 22 days) 
Control group (times 
for 22 days) 
Conjunctival redness (Score 1) 32 13 
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Evaluations of biomaterials using animal models 
Mar.08 ~ Sep.09 Fellow, Wilmer Eye Institute, MD, Baltimore 
Mentor: Roy S. Chuck M.D., Ph. D. 
Investigation of pathological mechanism of dry eye syndrome using a 
Botulinum toxin B-induced murine model 
Evaluation of redox state for cultured human corneal endothelial cells 
Sep.05 ~ Feb.08 Research assistant, Seoul National University, Seoul, Korea 
Mentor: Kangmoon Seo, D.V.M., Ph. D. 
Establishment of clinical criteria for veterinary ophthalmic practice 
Conduction of veterinary clinical trails for biomaterials. 
Oct.96 ~ Sep.98 Undergraduate student researcher, Konkuk University, Seoul, Korea 
Mentor: Jin-Suk Kim, D.V.M., Ph. D. 




May.05~Feb.08 Veterinary surgeon (specialty: Veterinary ophthalmology) 
Section of surgery and ophthalmology, Veterinary teaching hospital at 
Seoul National University, Seoul, Korea  
Sep.99~ Aug.04 Veterinary officer (Captain) 
Army, Korean National defense, Korea 
United nation army, United Nation Mission supporting East-Timor 
(UNMSET), East-Timor (2002/2 – 2002/10) 
TEACHING EXPERIENCE 
Fall 2013 Tissue engineering, Johns Hopkins University, MD, Baltimore 
Spring 2014 Molecular and cell biology, Johns Hopkins University, MD, Baltimore 
SELECTED PROFICIENCIES 
Selected Laboratory skill: Corneal cell culture (Limbal stem cell, Epithelial cell, Keratocyte, 
Endothelial cell), Gene work (PCR, RT-PCR, electrophoresis), Pathological work (chemical 
staining, Immunohistochemistry), Animal surgery (soft tissue, orthopedic, thoracic and 
ophthalmic surgery) and anesthesia (large animal, rodent, carnivore and non-human primate), 
Physicomechanial work (differential scanning calorimetry, rheometer, compressive modulus 
test) 
ORGANIZATIONS AND MEMBERSHIP 
2008 - Present Association for research in vision and ophthalmology (ARVO) 
HONORS AND AWARDS 
May. 2010 Mok-Am scientific foundation scholarship 
Apr. 2008 Wilmer research association, Wilmer research grant 
Feb. 2002 Military prize from Chief of General Staff in Korea 
Medal of honor - Peace Keeping Operation (Korean Army) 
Medal of peace (United Nation) 
166 
 
Mar 1998 KonKuk memorial Scholarship (scholarship tenure: 1998 ~ 1999) 
Mar 1995 KonKuk foundation Scholarship (scholarship tenure: 1995 ~ 1997) 
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